Loading…
Reported covered position: US SENATE BUDGET COMM, DPTY STAFF DIRECTOR
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Consolidated Appropriations Act, 2020
Client: JOHNSON & JOHNSON SERVICES, INC. · Firm: THE NICKLES GROUP, LLC
H.R. 1158, the Consolidated Appropriations Act of 2020 and H.R. 1865, Further Consolidated Appropriations Act, 2020.
Workplace Violence Prevention for Health Care and Social Service Workers Act
Client: AMERICAN HOSPITAL ASSOCIATION · Firm: THE NICKLES GROUP, LLC
Issues related to 42 CFR Part 2; monitored issues regarding drug pricing; issues related to S. 1895, Lower Health Care Costs Act of 2019. H.R. 1309, Workplace Violence Prevention for Health Care and Social Service Workers Act. H.R. 3630, No Surprises Act. H.R. 861, The End Surprise Billing Act. H.R. 3502, The Protecting People From Surprise Medical Bills Act. H.R. 5800, The Ban Surprise Medical Bill Act. P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act).
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
JOHNSON & JOHNSON SERVICES, INC. via THE NICKLES GROUP, LLC
2020 · fourth_quarter · 4A
S. 2543, Prescription Drug Pricing Reduction Act of 2019, issues related to ASP reporting; issues related to Medicare coverage of vaccines; issues related to H.R. 133, the Consolidated Appropriations Act of 2021, including vaccines, ASP reporting and liability. Monitored issues related to Most Favored Nation (MFN) rule and drug rebates.
Monitored issues related to S. 1895, Lower Health Care Costs Act of 2019; monitored issues related to P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act); issues related to maternal mortality.
Source: Senate LDA
| UCB, INC. |
| 37 |
| 2012–2020 |
| CIGNA CORPORATION | 34 | 2013–2020 |
| OWENS & MINOR, INC. | 34 | 2009–2016 |
| APRIA HEALTHCARE | 32 | 2005–2014 |
| QUALITY DIABETES CARE COALITION | 28 | 2008–2013 |
| SMITH & NEPHEW INC | 27 | 2014–2020 |
| ALCON LABORATORIES, INC. | 22 | 2005–2011 |
| BLUEBIRD BIO | 21 | 2016–2020 |
| METROPOLITAN LIFE INSURANCE COMPANY | 21 | 2014–2020 |
| MISSION HEALTH | 21 | 2014–2019 |
| NATIONAL MARROW DONOR PROGRAM | 21 | 2005–2010 |
| CUBIST PHARMACEUTICALS, INC. | 18 | 2010–2014 |
| ELI LILLY AND COMPANY | 18 | 2007–2013 |
| GUARDANT HEALTH | 18 | 2016–2020 |
| OMEROS CORPORATION | 18 | 2017–2020 |
| MERCK & CO., INC. | 17 | 2015–2018 |
| NOVARTIS CORPORATION | 17 | 2011–2014 |
| ACCENTURE LLP | 16 | 2016–2020 |
| HOFFMAN-LA ROCHE INC | 15 | 2006–2009 |
| AMERICAN DENTAL ASSOCIATION | 14 | 2008–2010 |
| EDITAS MEDICINE | 14 | 2017–2020 |
| SEND RELIEF, INC. | 13 | 2017–2020 |
| CSL BEHRING LLC | 12 | 2019–2020 |
| EHEALTH | 10 | 2016–2018 |
| JOHNSON & JOHNSON SERVICES, INC. | 10 | 2019–2020 |
| ACCENTURE FEDERAL SERVICES LLC | 9 | 2019–2020 |
| GILEAD SCIENCES, INC. | 9 | 2019–2020 |
| MANAGEMENT HEALTH SYSTEMS, LLC (D/B/A MEDPRO) | 8 | 2019–2020 |
| SIDECAR HEALTH, INC. | 8 | 2019–2020 |
| SONITUS MEDICAL INC. | 8 | 2013–2014 |
| GENERAL MOTORS LLC | 7 | 2005–2008 |
| MYRIAD GENETICS INC | 7 | 2019–2020 |
| ORACLE CORPORATION | 7 | 2015–2017 |
| THERANOS, INC. | 7 | 2015–2016 |
| BIONX MEDICAL TECHNOLOGIES, INC. | 6 | 2016–2017 |
| INVACARE CORPORATION | 6 | 2005–2007 |
| PFIZER, INC. | 5 | 2005–2007 |
| UNITEDHEALTH GROUP, INC. | 5 | 2015 |
| AMERICAN TRUCKING ASSOCIATIONS | 4 | 2020 |
| ORTHO-CLINICAL DIAGNOSTICS, INC. | 4 | 2020 |
| BEHRING INVESTMENTS (WHEELCHAIR/AQUA GLOBAL/GLOBAL HEALTH & ED FOUNDATIONS) | 3 | 2005 |
| KOCH GOVERNMENT AFFAIRS, LLC | 3 | 2014 |
| WALMART INC | 3 | 2014–2018 |
| COMPETE | 2 | 2005 |
| EMERGENT BIOSOLUTIONS | 2 | 2018–2019 |
| FEDERAL EXPRESS CORPORATION | 2 | 2012–2013 |
| GENERAL ELECTRIC COMPANY | 2 | 2005–2006 |
| GENWORTH FINANCIAL, INC. | 2 | 2017 |
| MERCHANTS PAYMENTS COALITION INC | 2 | 2008 |
| PHARMACEUTICAL RESEARCH & MANUFACURERS OF AMERICA (PHRMA) | 2 | 2005 |
| AIRPORTS COUNCIL INTERNATIONAL -- NORTH AMERICA | 1 | 2012 |
| CHARITY CAPITAL FUNDING PLAN | 1 | 2005 |
| YMCA OF THE USA | 1 | 2005 |
Workplace Violence Prevention for Health Care and Social Service Workers Act
Client: CLEVELAND CLINIC FOUNDATION · Firm: THE NICKLES GROUP, LLC
Issues regarding proposals to reduce health care costs; monitored issues related to drug pricing and drug shortages. Issues related to H.R. 1309, Workplace Violence Prevention for Health Care and Social Service Workers Act. Monitored issues related to price transparency. Monitored issues related to H.R. 3630, No Surprises Act, S. 1895, Lower Health Care Costs Act of 2019, H.R. 5800, Ban Surprise Billing Act, as it relates to surprise billing. Monitored S. 1399, Title VIII Nursing Workforce Reauthorization Act of 2019.
Workplace Violence Prevention for Health Care and Social Service Workers Act
Client: CLEVELAND CLINIC FOUNDATION · Firm: THE NICKLES GROUP, LLC
Issues regarding proposals to reduce health care costs; monitored issues related to drug pricing and drug shortages. Issues related to H.R. 1309, Workplace Violence Prevention for Health Care and Social Service Workers Act. Monitored issues related to price transparency. Monitored issues related to H.R. 3630, No Surprises Act, S. 1895, Lower Health Care Costs Act of 2019, H.R. 5800, Ban Surprise Billing Act, as it relates to surprise billing. Monitored S. 1399, Title VIII Nursing Workforce Reauthorization Act of 2019.
Consolidated Appropriations Act, 2021
Client: ORTHO-CLINICAL DIAGNOSTICS, INC. · Firm: THE NICKLES GROUP, LLC
Implementation issues related to P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act); funding issues related to antibody & antigen tests for COVID-19; H.R. 133, the Consolidated Appropriations Act of 2021, issues related to COVID testing.
Consolidated Appropriations Act, 2021
Client: SCAN HEALTH PLAN · Firm: THE NICKLES GROUP, LLC
H.R. 3461, Community-Based Independence for Seniors Act of 2019, issues related to Medicare advantage. Monitored implementation of P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act); issues related to telehealth; issues related to the Most Favored Nation (MFN) and drug rebate rule. H.R. 133, the Consolidated Appropriations Act of 2021, issues related to health extenders and telehealth.
Consolidated Appropriations Act, 2021
Client: AMERICAN HOSPITAL ASSOCIATION · Firm: THE NICKLES GROUP, LLC
H.R. 133, the Consolidated Appropriations Act of 2021, as it relates to provider relief fund and issues related to surprise medical billing.
Consolidated Appropriations Act, 2021
Client: MYRIAD GENETICS, INC. · Firm: THE NICKLES GROUP, LLC
Issues related to S. 3404, VALID Act. Monitored issues related to the implementation of P.L. 116-136., Coronavirus Aid, Response, and Economic Security Act (CARES Act). Issues related to S. 1895, the Lower Healthcare Cost Act including Surprise Medical Billing, issues related to H.R. 861, the End Surprise Billing Act, H.R. 5800, The Ban Surprise Billing Act; issues related to EKRA; H.R. 925 / H.R. 8406, The HEROES Act, issues related to COVID-19 testing and provider relief. H.R. 133, the Consolidated Appropriations Act of 2021, including surprise medical bill and COVID-19 testing.
Issues related to home infusion and DME self-administered therapies. Issues regarding coverage and reimbursement of biologics and plasma therapies. Monitored issues related to H.R. 2905, Medicare IVIG Access Enhancement Act. Monitored S. 2543, Prescription Drug Pricing Reduction Act of 2019. S. 3457 / H.R. 6218, Preserving Patient Access to Home Infusion Act, as it relates to access to drugs listed on the self-administered drug list. H.R. 7839, Continuing Access to In-Home IVIG Act. H.R. 133, the Consolidated Appropriations Act of 2021, including home infusion and DME self-administered therapies. Issues concerning the most favored nation rule as it relates to plasma-derived products.
Issues involving promoting plasma donation and convalescent plasma donation; issues involving the development hyperimmune globulin treatment; monitored issues related to H.R. 925 / H.R. 8406, The HEROES Act and The Health, Economic Assistance, Liability Protection and Schools (HEALS) Act; H.R. 8337, Continuing Appropriations Act, 2021 and Other Extensions Act; S. 4317, SAFE TO WORK Act; S. 4322, Safely Back to School and Back to Work Act. H.R. 133, the Consolidated Appropriations Act of 2021. Monitored S.AMDT 2562 to S. 178, Delivering Immediate Relief to Americas Families, Schools and Small Businesses Act.
Issues related to home infusion and DME self-administered therapies. Issues regarding coverage and reimbursement of biologics and plasma therapies. Monitored issues related to H.R. 2905, Medicare IVIG Access Enhancement Act. Monitored S. 2543, Prescription Drug Pricing Reduction Act of 2019. S. 3457 / H.R. 6218, Preserving Patient Access to Home Infusion Act, as it relates to access to drugs listed on the self-administered drug list. H.R. 7839, Continuing Access to In-Home IVIG Act. H.R. 133, the Consolidated Appropriations Act of 2021, including home infusion and DME self-administered therapies. Issues concerning the most favored nation rule as it relates to plasma-derived products.
Consolidated Appropriations Act, 2021
Client: AMERICAN HOSPITAL ASSOCIATION · Firm: THE NICKLES GROUP, LLC
H.R. 133, the Consolidated Appropriations Act of 2021, including issues related to sequestration relief, rural hospitals, provider relief funding and Medicaid DSH payments. Implementation of P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act).
Issues related to the implementation of P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act); issues related to the COVID-19 access to Part B drugs; issues related to the Most Favored Nation (MFN) and rebate rule; H.R. 133, the Consolidated Appropriations Act of 2021, issues related to reimbursement of self-administered drugs; issues related to the importation of prescription drugs.
Issues related to home infusion and DME self-administered therapies. Issues regarding coverage and reimbursement of biologics and plasma therapies. Monitored issues related to H.R. 2905, Medicare IVIG Access Enhancement Act. Monitored S. 2543, Prescription Drug Pricing Reduction Act of 2019. S. 3457 / H.R. 6218, Preserving Patient Access to Home Infusion Act, as it relates to access to drugs listed on the self-administered drug list. H.R. 7839, Continuing Access to In-Home IVIG Act. H.R. 133, the Consolidated Appropriations Act of 2021, including home infusion and DME self-administered therapies. Issues concerning the most favored nation rule as it relates to plasma-derived products.
Consolidated Appropriations Act, 2021
Client: AMERICAN SOCIETY OF ANESTHESIOLOGISTS · Firm: THE NICKLES GROUP, LLC
Issues related to rural anesthesiology; issues related to scope of practice; issues related to implementation of P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act); issues related to COVID-19 in anesthesiology; H.R. 133, the Consolidated Appropriations Act of 2021, as it relates to COVID relief and surprise medical billing.
Consolidated Appropriations Act, 2021
Client: GILEAD SCIENCES, INC. · Firm: THE NICKLES GROUP, LLC
Monitored issues related to COVID relief including H.R. 925 / H.R. 8406, The HEROES Act. Monitored H.R. 133, the Consolidated Appropriations Act of 2021.
H.R. 925 / H.R. 8406, The HEROES Act, S. 4317 the SAFE to WORK Act, S. Amdt. 2652 to S. 178, Delivering Immediate Relief to Americas Families, Schools and Small Businesses Act, H.R. 133, the Consolidated Appropriations Act of 2021, as they relate to COVID liability relief.
Consolidated Appropriations Act, 2021
Client: AMERICAN HOSPITAL ASSOCIATION · Firm: THE NICKLES GROUP, LLC
H.R. 133, the Consolidated Appropriations Act of 2021, including issues related to sequestration relief, rural hospitals, provider relief funding and Medicaid DSH payments. Implementation of P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act).
Consolidated Appropriations Act, 2021
Client: SCAN HEALTH PLAN · Firm: THE NICKLES GROUP, LLC
H.R. 133, the Consolidated Appropriations Act of 2021, issues related to health extenders and telehealth.
Consolidated Appropriations Act, 2021
Client: AMERICAN HOSPITAL ASSOCIATION · Firm: THE NICKLES GROUP, LLC
H.R. 133, the Consolidated Appropriations Act of 2021, as it relates to provider relief fund and issues related to surprise medical billing.
Issues related to home infusion and DME self-administered therapies. Issues regarding coverage and reimbursement of biologics and plasma therapies. Monitored issues related to H.R. 2905, Medicare IVIG Access Enhancement Act. Monitored S. 2543, Prescription Drug Pricing Reduction Act of 2019. S. 3457 / H.R. 6218, Preserving Patient Access to Home Infusion Act, as it relates to access to drugs listed on the self-administered drug list. H.R. 7839, Continuing Access to In-Home IVIG Act. H.R. 133, the Consolidated Appropriations Act of 2021, including home infusion and DME self-administered therapies. Issues concerning the most favored nation rule as it relates to plasma-derived products.
Issues involving promoting plasma donation and convalescent plasma donation; issues involving the development hyperimmune globulin treatment; monitored issues related to H.R. 925 / H.R. 8406, The HEROES Act and The Health, Economic Assistance, Liability Protection and Schools (HEALS) Act; H.R. 8337, Continuing Appropriations Act, 2021 and Other Extensions Act; S. 4317, SAFE TO WORK Act; S. 4322, Safely Back to School and Back to Work Act. H.R. 133, the Consolidated Appropriations Act of 2021. Monitored S.AMDT 2562 to S. 178, Delivering Immediate Relief to Americas Families, Schools and Small Businesses Act.
Consolidated Appropriations Act, 2021
Client: CLEVELAND CLINIC FOUNDATION · Firm: THE NICKLES GROUP, LLC
Monitored issues related to prescription drug pricing. Issues regarding telehealth. Issues regarding PPS exempt hospitals. Issues regarding price transparency. H.R. 8337, Continuing Appropriations Act, 2021 and Other Extensions Act, as it relates to accelerated payments and Medicaid DSH. H.R. 7791, Value in Health Care Act of 2020. Implementation of P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act), as it relates to provider funding. H.R. 133, The Consolidated Appropriations Act of 2021 including provider relief funding, Medicaid DSH, surprise billing, sequestration relief, testing, vaccines and liability reform.
Consolidated Appropriations Act, 2021
Client: JOHNSON & JOHNSON SERVICES, INC. · Firm: THE NICKLES GROUP, LLC
S. 2543, Prescription Drug Pricing Reduction Act of 2019, issues related to ASP reporting; issues related to Medicare coverage of vaccines; issues related to H.R. 133, the Consolidated Appropriations Act of 2021, including vaccines, ASP reporting and liability. Monitored issues related to Most Favored Nation (MFN) rule and drug rebates.
Issues involving promoting plasma donation and convalescent plasma donation; issues involving the development hyperimmune globulin treatment; monitored issues related to H.R. 925 / H.R. 8406, The HEROES Act and The Health, Economic Assistance, Liability Protection and Schools (HEALS) Act; H.R. 8337, Continuing Appropriations Act, 2021 and Other Extensions Act; S. 4317, SAFE TO WORK Act; S. 4322, Safely Back to School and Back to Work Act. H.R. 133, the Consolidated Appropriations Act of 2021. Monitored S.AMDT 2562 to S. 178, Delivering Immediate Relief to Americas Families, Schools and Small Businesses Act.
Consolidated Appropriations Act, 2021
Client: JOHNSON & JOHNSON SERVICES, INC. · Firm: THE NICKLES GROUP, LLC
S. 2543, Prescription Drug Pricing Reduction Act of 2019, issues related to ASP reporting; issues related to Medicare coverage of vaccines; issues related to H.R. 133, the Consolidated Appropriations Act of 2021, including vaccines, ASP reporting and liability. Monitored issues related to Most Favored Nation (MFN) rule and drug rebates.
Consolidated Appropriations Act, 2021
Client: OMEROS CORPORATION · Firm: THE NICKLES GROUP, LLC
Monitored issues related to prescription drug prices; H.R. 5172, NOPAIN Act and S. 3067, Non-Opioids Prevent Addiction In the Nation Act and issues involving access to patients to non-opioid alternatives; issues related to the 2021 OPPS final rule; monitored issues related to H.R. 133, the Consolidated Appropriations Act of 2021.
Issues involving promoting plasma donation and convalescent plasma donation; issues involving the development hyperimmune globulin treatment; monitored issues related to H.R. 925 / H.R. 8406, The HEROES Act and The Health, Economic Assistance, Liability Protection and Schools (HEALS) Act; H.R. 8337, Continuing Appropriations Act, 2021 and Other Extensions Act; S. 4317, SAFE TO WORK Act; S. 4322, Safely Back to School and Back to Work Act. H.R. 133, the Consolidated Appropriations Act of 2021. Monitored S.AMDT 2562 to S. 178, Delivering Immediate Relief to Americas Families, Schools and Small Businesses Act.
Consolidated Appropriations Act, 2021
Client: MYRIAD GENETICS, INC. · Firm: THE NICKLES GROUP, LLC
Issues related to laboratory developed tests and reimbursement; issues related to the implementation of P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act). Issues related to the 2020 OPPS rule specifically related to packaging policy. Monitored issues related to H.R. 133, the Consolidated Appropriations Act of 2021, as it relates to surprise medical billing. Issues related to provider relief fund.
S. 2543 Prescription Drug Pricing Act and issues related to value based payment over time; H.R. 5882 Gene Therapy Payment Act; H.R. 3935, the Protecting Patients Transportation to Care Act; issues related to the Notice of Proposed rulemaking supporting VBP Arrangement; monitored issues related to H.R. 133, the Consolidated Appropriations Act of 2021; monitored issues related to the Most Favored Nation (MFN) rule.
Consolidated Appropriations Act, 2021
Client: SMITH & NEPHEW, INC. · Firm: THE NICKLES GROUP, LLC
H.R. 8624, Protecting Access to Innovation During COVID-19 Act; H.R. 7127, and issues related to disposable negative pressure wound therapy; issues related to telehealth; monitored implementation of P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act); monitored issues related to the Most Favored Nation (MFN) rule. H.R. 133, the Consolidated Appropriations Act of 2021, and issues related to health extenders.
Consolidated Appropriations Act, 2021
Client: BRISTOL-MYERS SQUIBB COMPANY · Firm: THE NICKLES GROUP, LLC
Most Favored Nation (MFN) rule & drug rebates; H.R. 133, the Consolidated Appropriations Act of 2021, issues related to COVID-19, and the reimbursement of self-administered drugs.
Consolidated Appropriations Act, 2021
Client: CIGNA CORPORATION · Firm: THE NICKLES GROUP, LLC
H.R. 7839, Continuing Access to In-Home IVIG Act. Monitored issues related to H.R. 133, the Consolidated Appropriations Act of 2021 / PL 116-260 - FY2021 Omnibus and COVID Relief and Response Act, including access to IVIG and telehealth. Issues related to Medicare Advantage plans.
Monitored issues related to the regulation of laboratory developed tests and the VALID Act. Monitored H.R. 1765, Donald Payne Sr. Colorectal Cancer Detection Act of 2019. Monitored implementation of P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act). Issues related to P.L. 115-271, The SUPPORT Act; monitored issues related to H.R. 133, the Consolidated Appropriations Act of 2021.
Consolidated Appropriations Act, 2021
Client: CIGNA CORPORATION · Firm: THE NICKLES GROUP, LLC
Issues related to S.1895, the Lower Health Care Costs Act of 2019, and issues related to transparency. Issues related to H.R. 133, the Consolidated Appropriations Act of 2021 / PL 116-260 - FY2021 Omnibus and COVID Relief and Response Act, including COVID-19 testing and surprise medical billing.
Consolidated Appropriations Act, 2021
Client: ACCENTURE FEDERAL SERVICES LLC · Firm: THE NICKLES GROUP, LLC
Monitored issues related to the Affordable Care Act and the federal exchange; issues related to vaccines management. Monitored issues related to H.R. 133, the Consolidated Appropriations Act of 2021, as it relates to vaccines.
Donald Payne Sr. Colorectal Cancer Detection Act of 2019
Client: GUARDANT HEALTH · Firm: THE NICKLES GROUP, LLC
Monitored issues related to the regulation of laboratory developed tests and the VALID Act; issues related to liquid biopsy; S. 1895, Lower Health Care Costs Act of 2019; H.R. 861, End Surprise Billing Act of 2019. Monitored H.R. 1765, Donald Payne Sr. Colorectal Cancer Detection Act of 2019. P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act). Issues related to P.L. 115-271, The SUPPORT Act.
Donald Payne Sr. Colorectal Cancer Detection Act of 2019
Client: GUARDANT HEALTH · Firm: THE NICKLES GROUP, LLC
Monitored issues related to the regulation of laboratory developed tests and the VALID Act. Monitored H.R. 1765, Donald Payne Sr. Colorectal Cancer Detection Act of 2019. Monitored implementation of P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act). Issues related to P.L. 115-271, The SUPPORT Act; monitored issues related to H.R. 133, the Consolidated Appropriations Act of 2021.
Donald Payne Sr. Colorectal Cancer Detection Act of 2019
Client: GUARDANT HEALTH · Firm: THE NICKLES GROUP, LLC
Monitored issues related to the regulation of laboratory developed tests and the VALID Act; issues related to liquid biopsy; S. 1895, Lower Health Care Costs Act of 2019; H.R. 861, End Surprise Billing Act of 2019. Monitored H.R. 1765, Donald Payne Sr. Colorectal Cancer Detection Act of 2019. P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act). Issues related to P.L. 115-271, The SUPPORT Act; H.R. 925 / H.R. 8406, The HEROES Act and The Health, Economic Assistance, Liability Protection and Schools (HEALS) Act, related to COVID testing.
Donald Payne Sr. Colorectal Cancer Detection Act of 2019
Client: GUARDANT HEALTH · Firm: THE NICKLES GROUP, LLC
Monitored issues related to the regulation of laboratory developed tests and the VALID Act; issues related to liquid biopsy; S. 1895, Lower Health Care Costs Act of 2019; H.R. 861, End Surprise Billing Act of 2019. Monitored H.R. 1765, Donald Payne Sr. Colorectal Cancer Detection Act of 2019. P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act). Issues related to P.L. 115-271, The SUPPORT Act.
Further Consolidated Appropriations Act, 2020
Client: JOHNSON & JOHNSON SERVICES, INC. · Firm: THE NICKLES GROUP, LLC
H.R. 1158, the Consolidated Appropriations Act of 2020 and H.R. 1865, Further Consolidated Appropriations Act, 2020.
Setting Every Community Up for Retirement Enhancement Act of 2019
Client: METROPOLITAN LIFE INSURANCE COMPANY · Firm: THE NICKLES GROUP, LLC
Issues related to the implementation of The Tax Cut and Jobs Act, in particular the taxation of insurance and the taxation of foreign earnings of U.S. multinational corporations. S. 972, the Retirement Enhancement and Savings Act of 2019 and H.R. 1994, the SECURE Act, as they relate to employer pensions plans. Issues related to the Health Insurance Tax.
Monitored issues related to prescription drug pricing. H.R. 2296, the METRIC Act. Monitored S. 1895, Lower Health Care Costs Act of 2019, as it relates to pricing transparency and drug pricing. H.R. 2113, Prescription Drug STAR Act.
Issues related to home infusion and DME self-administered therapies. Issues regarding coverage and reimbursement of biologics and plasma therapies. Issues pertaining to drugs listed on the Self-Administered Drug list. H.R. 2296, the METRIC Act. Monitored issues related to H.R. 2905, Medicare IVIG Access Enhancement Act. H.R. 2113, Prescription Drug STAR Act. Monitored S. 2543, Prescription Drug Pricing Reduction Act of 2019. H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act. S. 3457 / H.R. 6218, Preserving Patient Access to Home Infusion Act, as it relates to access to drugs listed on the self-administered drug list. Monitored Coronavirus Aid, Relief and Economic Security "CARES Act," P.L. 116-136.
Issues related to unique device identifiers; monitored issues related to the regulation of medical devices. Monitored H.R. 2113, Prescription Drug STAR Act, as it relates to sample device products.
More Efficient Tools to Realize Information for Consumers Act
Client: CSL BEHRING LLC · Firm: THE NICKLES GROUP, LLC
Issues related to home infusion and DME self-administered therapies. Issues regarding coverage and reimbursement of biologics and plasma therapies. Issues pertaining to drugs listed on the Self-Administered Drug list. H.R. 2296, the METRIC Act. Monitored issues related to H.R. 2905, Medicare IVIG Access Enhancement Act. H.R. 2113, Prescription Drug STAR Act. Monitored S. 2543, Prescription Drug Pricing Reduction Act of 2019. H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act. S. 3457 / H.R. 6218, Preserving Patient Access to Home Infusion Act, as it relates to access to drugs listed on the self-administered drug list. Monitored Coronavirus Aid, Relief and Economic Security "CARES Act," P.L. 116-136.
More Efficient Tools to Realize Information for Consumers Act
Client: CSL BEHRING LLC · Firm: THE NICKLES GROUP, LLC
Monitored issues related to prescription drug pricing. H.R. 2296, the METRIC Act. Monitored S. 1895, Lower Health Care Costs Act of 2019, as it relates to pricing transparency and drug pricing. H.R. 2113, Prescription Drug STAR Act.
Monitored issues related to surprise medical bills including H.R 3502, H.R. 861, H.R. 3630, H.R 2328; issues related to S.1895 the Lower Health Care Costs Act of 2019 and issues related to transparency. Issues related to P.L. 116-123, the Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020; P.L. 116-127, Families First Coronavirus Response Act. P.L. 116-136., Coronavirus Aid, Response, and Economic Security Act (CARES Act).
Monitored issues related to surprise medical bills including H.R 3502, H.R. 861, H.R. 3630, H.R 2328; issues related to S.1895 the Lower Health Care Costs Act of 2019 and issues related to transparency; implementation issues related to P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act); issues related to COBRA subsidies. The Health, Economic Assistance, Liability Protection and Schools (HEALS) Act and H.R. 925/H.R. 8406, The HEROES Act and issues related to COVID-19 testing.
Monitored issues related to surprise medical bills including H.R 3502, H.R. 861, H.R. 3630, H.R 2328; issues related to S.1895 the Lower Health Care Costs Act of 2019 and issues related to transparency; implementation issues related to P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act); issues related to COBRA subsidies.
Monitored issues related to surprise medical bills including H.R 3502, H.R. 861, H.R. 3630, H.R 2328; issues related to S.1895 the Lower Health Care Costs Act of 2019 and issues related to transparency; implementation issues related to P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act); issues related to COBRA subsidies. The Health, Economic Assistance, Liability Protection and Schools (HEALS) Act and H.R. 925/H.R. 8406, The HEROES Act and issues related to testing.
Issues related to home infusion and DME self-administered therapies. Issues regarding coverage and reimbursement of biologics and plasma therapies. Issues pertaining to drugs listed on the Self-Administered Drug list. H.R. 2296, the METRIC Act. Monitored issues related to H.R. 2905, Medicare IVIG Access Enhancement Act. H.R. 2113, Prescription Drug STAR Act. Monitored S. 2543, Prescription Drug Pricing Reduction Act of 2019. H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act. S. 3457 / H.R. 6218, Preserving Patient Access to Home Infusion Act, as it relates to access to drugs listed on the self-administered drug list. Monitored Coronavirus Aid, Relief and Economic Security "CARES Act," P.L. 116-136.
Issues related to home infusion and DME self-administered therapies. Issues regarding coverage and reimbursement of biologics and plasma therapies. Monitored issues related to H.R. 2905, Medicare IVIG Access Enhancement Act. Monitored S. 2543, Prescription Drug Pricing Reduction Act of 2019. S. 3457 / H.R. 6218, Preserving Patient Access to Home Infusion Act, as it relates to access to drugs listed on the self-administered drug list. H.R. 7839, Continuing Access to In-Home IVIG Act. H.R. 133, the Consolidated Appropriations Act of 2021, including home infusion and DME self-administered therapies. Issues concerning the most favored nation rule as it relates to plasma-derived products.
Issues related to home infusion and DME self-administered therapies. Issues regarding coverage and reimbursement of biologics and plasma therapies. Monitored issues related to H.R. 2905, Medicare IVIG Access Enhancement Act. Monitored S. 2543, Prescription Drug Pricing Reduction Act of 2019. S. 3457 / H.R. 6218, Preserving Patient Access to Home Infusion Act, as it relates to access to drugs listed on the self-administered drug list. H.R. 7839, Continuing Access to In-Home IVIG Act. H.R. 133, the Consolidated Appropriations Act of 2021, including home infusion and DME self-administered therapies. Issues concerning the most favored nation rule as it relates to plasma-derived products.
Issues related to home infusion and DME self-administered therapies. Issues regarding coverage and reimbursement of biologics and plasma therapies. Monitored issues related to H.R. 2905, Medicare IVIG Access Enhancement Act. Monitored S. 2543, Prescription Drug Pricing Reduction Act of 2019. S. 3457 / H.R. 6218, Preserving Patient Access to Home Infusion Act, as it relates to access to drugs listed on the self-administered drug list. Issues related to the Executive Order on Lowering Drug Prices by Putting America First. H.R. 7839, Continuing Access to In-Home IVIG Act.
Issues related to home infusion and DME self-administered therapies. Issues regarding coverage and reimbursement of biologics and plasma therapies. Issues pertaining to drugs listed on the Self-Administered Drug list. Monitored issues related to H.R. 2905, Medicare IVIG Access Enhancement Act. Monitored S. 2543, Prescription Drug Pricing Reduction Act of 2019. S. 3457 / H.R. 6218, Preserving Patient Access to Home Infusion Act, as it relates to access to drugs listed on the self-administered drug list. Monitored issues related to drug pricing. Issues related to the corona virus.
Issues related to home infusion and DME self-administered therapies. Issues regarding coverage and reimbursement of biologics and plasma therapies. Monitored issues related to H.R. 2905, Medicare IVIG Access Enhancement Act. Monitored S. 2543, Prescription Drug Pricing Reduction Act of 2019. S. 3457 / H.R. 6218, Preserving Patient Access to Home Infusion Act, as it relates to access to drugs listed on the self-administered drug list. H.R. 7839, Continuing Access to In-Home IVIG Act. H.R. 133, the Consolidated Appropriations Act of 2021, including home infusion and DME self-administered therapies. Issues concerning the most favored nation rule as it relates to plasma-derived products.
Issues related to home infusion and DME self-administered therapies. Issues regarding coverage and reimbursement of biologics and plasma therapies. Monitored issues related to H.R. 2905, Medicare IVIG Access Enhancement Act. Monitored S. 2543, Prescription Drug Pricing Reduction Act of 2019. S. 3457 / H.R. 6218, Preserving Patient Access to Home Infusion Act, as it relates to access to drugs listed on the self-administered drug list. H.R. 7839, Continuing Access to In-Home IVIG Act. H.R. 133, the Consolidated Appropriations Act of 2021, including home infusion and DME self-administered therapies. Issues concerning the most favored nation rule as it relates to plasma-derived products.
Elijah E. Cummings Lower Drug Costs Now Act
Client: JOHNSON & JOHNSON SERVICES, INC. · Firm: THE NICKLES GROUP, LLC
Issues related to biosimilars; S. 2543, Prescription Drug Pricing Reduction Act of 2019, issues related to ASP reporting; H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act.
Elijah E. Cummings Lower Drug Costs Now Act
Client: SMITH & NEPHEW, INC. · Firm: THE NICKLES GROUP, LLC
Issues related to unique device identifiers; monitored issues related to drug pricing; issues related to disposable negative pressure wound therapy; S. 2543, Prescription Drug Pricing Reduction Act of 2019; H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act.
Elijah E. Cummings Lower Drug Costs Now Act
Client: AMERICAN HOSPITAL ASSOCIATION · Firm: THE NICKLES GROUP, LLC
Monitored issues related to price transparency; issues related to rural hospitals; issues related to Medicaid DSH payments; H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act. P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act). S. 2543, The Prescription Drug Pricing Reduction Act of 2019.
Elijah E. Cummings Lower Drug Costs Now Act
Client: CSL BEHRING LLC · Firm: THE NICKLES GROUP, LLC
Issues related to home infusion and DME self-administered therapies. Issues regarding coverage and reimbursement of biologics and plasma therapies. Issues pertaining to drugs listed on the Self-Administered Drug list. H.R. 2296, the METRIC Act. Monitored issues related to H.R. 2905, Medicare IVIG Access Enhancement Act. H.R. 2113, Prescription Drug STAR Act. Monitored S. 2543, Prescription Drug Pricing Reduction Act of 2019. H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act. S. 3457 / H.R. 6218, Preserving Patient Access to Home Infusion Act, as it relates to access to drugs listed on the self-administered drug list. Monitored Coronavirus Aid, Relief and Economic Security "CARES Act," P.L. 116-136.
Elijah E. Cummings Lower Drug Costs Now Act
Client: BLUEBIRD BIO · Firm: THE NICKLES GROUP, LLC
Issues related to drug pricing including S. 2543 Prescription Drug pricing Act and issues related to value based payment over time; H.R. 5882 the GENE Therapy Payment Act; H.R. 3 Elijah E. Cummings lower drug costs act; issues related to Medicaid Best Price and AMP reporting. Issues related to H.R. 3935, the Protecting Patients Transportation to Care Act.
Elijah E. Cummings Lower Drug Costs Now Act
Client: GILEAD SCIENCES, INC. · Firm: THE NICKLES GROUP, LLC
Issues related to the reimbursement of CAR-T therapy; monitored issues related to S. 2543, Prescription Drug Pricing Reduction Act of 2019 and H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act.
S. 2543, Prescription Drug Pricing Reduction Act of 2019 and issues related to the reimbursement of Part B and D drugs; and H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act. P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act).
Elijah E. Cummings Lower Drug Costs Now Act
Client: CIGNA CORPORATION · Firm: THE NICKLES GROUP, LLC
Monitored issues related to the safe harbor protection. S. 2543 The Prescription Drug Pricing Reduction Act of 2019; issues related to Medicare Advantage; issues related to Price Transparency; issues related to H.R. 3, the Elijah E. Cummings Lower Cost Act of 2019.
Elijah E. Cummings Lower Drug Costs Now Act
Client: BRISTOL-MYERS SQUIBB COMPANY · Firm: THE NICKLES GROUP, LLC
Issues related to S. 2543, The Prescription Drug Pricing Reduction Act of 2019 and including Part D and Part B; issues related to the IPI CMMI demonstration; monitored issues related to H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act; issues related to the reimbursement of CAR-T therapy.
Community-Based Independence for Seniors Act of 2019
Client: SCAN HEALTH PLAN · Firm: THE NICKLES GROUP, LLC
H.R. 3461, Community-Based Independence for Seniors Act of 2019, issues related to Medicare advantage. P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act).
Community-Based Independence for Seniors Act of 2019
Client: SCAN HEALTH PLAN · Firm: THE NICKLES GROUP, LLC
H.R. 3461, Community-Based Independence for Seniors Act of 2019, issues related to Medicare advantage. Monitored implementation of P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act); issues related to telehealth.
Community-Based Independence for Seniors Act of 2019
Client: SCAN HEALTH PLAN · Firm: THE NICKLES GROUP, LLC
H.R. 3461, Community-Based Independence for Seniors Act of 2019, issues related to Medicare advantage. Monitored implementation of P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act); issues related to telehealth; issues related to the Executive Order on Lowering Drug Prices by Putting America First.
Community-Based Independence for Seniors Act of 2019
Client: SCAN HEALTH PLAN · Firm: THE NICKLES GROUP, LLC
H.R. 3461, Community-Based Independence for Seniors Act of 2019, issues related to Medicare advantage. Monitored implementation of P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act); issues related to telehealth; issues related to the Most Favored Nation (MFN) and drug rebate rule. H.R. 133, the Consolidated Appropriations Act of 2021, issues related to health extenders and telehealth.
Protecting People From Surprise Medical Bills Act
Client: AMERICAN SOCIETY OF ANESTHESIOLOGISTS · Firm: THE NICKLES GROUP, LLC
Issues related to drug shortages; issues related to scope of practice; S. 1895, Lower Health Care Costs Act of 2019; H.R. 861, End Surprise Billing Act of 2019; H.R. 3630, No Surprises Act; H.R. 3502, Protecting People from Surprise Medical Bills Act. P.L. 116-136., Coronavirus Aid, Response, and Economic Security Act (CARES Act). Issues related to H.R. 925 / H.R. 8406, The HEROES Act and The Health, Economic Assistance, Liability Protection and Schools (HEALS) Act.
Protecting People From Surprise Medical Bills Act
Client: AMERICAN SOCIETY OF ANESTHESIOLOGISTS · Firm: THE NICKLES GROUP, LLC
Issues related to drug shortages; issues related to scope of practice; S. 1895, Lower Health Care Costs Act of 2019; H.R. 861, End Surprise Billing Act of 2019; H.R. 3630, No Surprises Act; H.R. 3502, Protecting People from Surprise Medical Bills Act. P.L. 116-136., Coronavirus Aid, Response, and Economic Security Act (CARES Act).
Protecting People From Surprise Medical Bills Act
Client: CIGNA CORPORATION · Firm: THE NICKLES GROUP, LLC
Monitored issues related to surprise medical bills including H.R 3502, H.R. 861, H.R. 3630, H.R 2328; issues related to S.1895 the Lower Health Care Costs Act of 2019 and issues related to transparency; implementation issues related to P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act); issues related to COBRA subsidies. The Health, Economic Assistance, Liability Protection and Schools (HEALS) Act and H.R. 925/H.R. 8406, The HEROES Act and issues related to testing.
Protecting People From Surprise Medical Bills Act
Client: AMERICAN HOSPITAL ASSOCIATION · Firm: THE NICKLES GROUP, LLC
Issues related to S. 1895, Lower Health Care Costs Act of 2019. H.R. 3630, No Surprises Act. H.R. 861, The End Surprise Billing Act. H.R. 3502, The Protecting People From Surprise Medical Bills Act. H.R. 5800, The Ban Surprise Medical Bill Act.
Protecting People From Surprise Medical Bills Act
Client: CIGNA CORPORATION · Firm: THE NICKLES GROUP, LLC
Monitored issues related to surprise medical bills including H.R 3502, H.R. 861, H.R. 3630, H.R 2328; issues related to S.1895 the Lower Health Care Costs Act of 2019 and issues related to transparency; implementation issues related to P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act); issues related to COBRA subsidies. The Health, Economic Assistance, Liability Protection and Schools (HEALS) Act and H.R. 925/H.R. 8406, The HEROES Act and issues related to COVID-19 testing.
Protecting People From Surprise Medical Bills Act
Client: AMERICAN SOCIETY OF ANESTHESIOLOGISTS · Firm: THE NICKLES GROUP, LLC
Issues related to drug shortages; issues related to scope of practice; S. 1895, Lower Health Care Costs Act of 2019; H.R. 861, End Surprise Billing Act of 2019; H.R. 3630, No Surprises Act; H.R. 3502, Protecting People from Surprise Medical Bills Act. P.L. 116-136., Coronavirus Aid, Response, and Economic Security Act (CARES Act).
Protecting People From Surprise Medical Bills Act
Client: AMERICAN HOSPITAL ASSOCIATION · Firm: THE NICKLES GROUP, LLC
Issues related to 42 CFR Part 2; monitored issues regarding drug pricing; issues related to S. 1895, Lower Health Care Costs Act of 2019. H.R. 1309, Workplace Violence Prevention for Health Care and Social Service Workers Act. H.R. 3630, No Surprises Act. H.R. 861, The End Surprise Billing Act. H.R. 3502, The Protecting People From Surprise Medical Bills Act. H.R. 5800, The Ban Surprise Medical Bill Act. P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act).
Protecting People From Surprise Medical Bills Act
Client: CIGNA CORPORATION · Firm: THE NICKLES GROUP, LLC
Monitored issues related to surprise medical bills including H.R 3502, H.R. 861, H.R. 3630, H.R 2328; issues related to S.1895 the Lower Health Care Costs Act of 2019 and issues related to transparency. Issues related to P.L. 116-123, the Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020; P.L. 116-127, Families First Coronavirus Response Act. P.L. 116-136., Coronavirus Aid, Response, and Economic Security Act (CARES Act).
Protecting People From Surprise Medical Bills Act
Client: CIGNA CORPORATION · Firm: THE NICKLES GROUP, LLC
Monitored issues related to surprise medical bills including H.R 3502, H.R. 861, H.R. 3630, H.R 2328; issues related to S.1895 the Lower Health Care Costs Act of 2019 and issues related to transparency; implementation issues related to P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act); issues related to COBRA subsidies.
Protecting People From Surprise Medical Bills Act
Client: AMERICAN HOSPITAL ASSOCIATION · Firm: THE NICKLES GROUP, LLC
Issues related to S. 1895, Lower Health Care Costs Act of 2019. H.R. 3630, No Surprises Act. H.R. 861, The End Surprise Billing Act. H.R. 3502, The Protecting People From Surprise Medical Bills Act. H.R. 5800, The Ban Surprise Medical Bill Act.
Monitored issues related to surprise medical bills including H.R 3502, H.R. 861, H.R. 3630, H.R 2328; issues related to S.1895 the Lower Health Care Costs Act of 2019 and issues related to transparency; implementation issues related to P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act); issues related to COBRA subsidies.
Monitored issues related to surprise medical bills including H.R 3502, H.R. 861, H.R. 3630, H.R 2328; issues related to S.1895 the Lower Health Care Costs Act of 2019 and issues related to transparency; implementation issues related to P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act); issues related to COBRA subsidies. The Health, Economic Assistance, Liability Protection and Schools (HEALS) Act and H.R. 925/H.R. 8406, The HEROES Act and issues related to testing.
Monitored issues related to surprise medical bills including H.R 3502, H.R. 861, H.R. 3630, H.R 2328; issues related to S.1895 the Lower Health Care Costs Act of 2019 and issues related to transparency; implementation issues related to P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act); issues related to COBRA subsidies. The Health, Economic Assistance, Liability Protection and Schools (HEALS) Act and H.R. 925/H.R. 8406, The HEROES Act and issues related to COVID-19 testing.
Monitored issues related to surprise medical bills including H.R 3502, H.R. 861, H.R. 3630, H.R 2328; issues related to S.1895 the Lower Health Care Costs Act of 2019 and issues related to transparency. Issues related to P.L. 116-123, the Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020; P.L. 116-127, Families First Coronavirus Response Act. P.L. 116-136., Coronavirus Aid, Response, and Economic Security Act (CARES Act).
Issues regarding proposals to reduce health care costs; monitored issues related to drug pricing and drug shortages. Issues related to H.R. 1309, Workplace Violence Prevention for Health Care and Social Service Workers Act. Monitored issues related to price transparency. Monitored issues related to H.R. 3630, No Surprises Act, S. 1895, Lower Health Care Costs Act of 2019, H.R. 5800, Ban Surprise Billing Act, as it relates to surprise billing. Monitored S. 1399, Title VIII Nursing Workforce Reauthorization Act of 2019.
No Surprises Act
Client: AMERICAN SOCIETY OF ANESTHESIOLOGISTS · Firm: THE NICKLES GROUP, LLC
Issues related to drug shortages; issues related to scope of practice; S. 1895, Lower Health Care Costs Act of 2019; H.R. 861, End Surprise Billing Act of 2019; H.R. 3630, No Surprises Act; H.R. 3502, Protecting People from Surprise Medical Bills Act. P.L. 116-136., Coronavirus Aid, Response, and Economic Security Act (CARES Act).
Issues related to 42 CFR Part 2; monitored issues regarding drug pricing; issues related to S. 1895, Lower Health Care Costs Act of 2019. H.R. 1309, Workplace Violence Prevention for Health Care and Social Service Workers Act. H.R. 3630, No Surprises Act. H.R. 861, The End Surprise Billing Act. H.R. 3502, The Protecting People From Surprise Medical Bills Act. H.R. 5800, The Ban Surprise Medical Bill Act. P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act).
No Surprises Act
Client: AMERICAN SOCIETY OF ANESTHESIOLOGISTS · Firm: THE NICKLES GROUP, LLC
Issues related to drug shortages; issues related to scope of practice; S. 1895, Lower Health Care Costs Act of 2019; H.R. 861, End Surprise Billing Act of 2019; H.R. 3630, No Surprises Act; H.R. 3502, Protecting People from Surprise Medical Bills Act. P.L. 116-136., Coronavirus Aid, Response, and Economic Security Act (CARES Act).
No Surprises Act
Client: AMERICAN SOCIETY OF ANESTHESIOLOGISTS · Firm: THE NICKLES GROUP, LLC
Issues related to drug shortages; issues related to scope of practice; S. 1895, Lower Health Care Costs Act of 2019; H.R. 861, End Surprise Billing Act of 2019; H.R. 3630, No Surprises Act; H.R. 3502, Protecting People from Surprise Medical Bills Act. P.L. 116-136., Coronavirus Aid, Response, and Economic Security Act (CARES Act). Issues related to H.R. 925 / H.R. 8406, The HEROES Act and The Health, Economic Assistance, Liability Protection and Schools (HEALS) Act.
Issues related to S. 1895, Lower Health Care Costs Act of 2019. H.R. 3630, No Surprises Act. H.R. 861, The End Surprise Billing Act. H.R. 3502, The Protecting People From Surprise Medical Bills Act. H.R. 5800, The Ban Surprise Medical Bill Act.
Issues regarding proposals to reduce health care costs; monitored issues related to drug pricing and drug shortages. Issues related to H.R. 1309, Workplace Violence Prevention for Health Care and Social Service Workers Act. Monitored issues related to price transparency. Monitored issues related to H.R. 3630, No Surprises Act, S. 1895, Lower Health Care Costs Act of 2019, H.R. 5800, Ban Surprise Billing Act, as it relates to surprise billing. Monitored S. 1399, Title VIII Nursing Workforce Reauthorization Act of 2019.
Monitored issues related to drug pricing and drug shortages. Monitored issues related to price transparency. Monitored issues related to H.R. 3630, No Surprises Act, S. 1895, Lower Health Care Costs Act of 2019, H.R. 5800, Ban Surprise Billing Act, as it relates to surprise billing. Monitored S. 1399, Title VIII Nursing Workforce Reauthorization Act of 2019; S. 4317, SAFE TO WORK Act; S. 4322, Safely Back to School and Back to Work Act; issues related to H.R. 925 / H.R. 8406, The HEROES Act and The Health, Economic Assistance, Liability Protection and Schools (HEALS) Act. H.R. 8283, Temporary Reciprocity to Ensure Access to Treatment (TREAT) Act.
Monitored issues related to drug pricing and drug shortages. Monitored issues related to price transparency. Monitored issues related to H.R. 3630, No Surprises Act, S. 1895, Lower Health Care Costs Act of 2019, H.R. 5800, Ban Surprise Billing Act, as it relates to surprise billing. Monitored S. 1399, Title VIII Nursing Workforce Reauthorization Act of 2019; S. 4317, SAFE TO WORK Act; S. 4322, Safely Back to School and Back to Work Act; issues related to H.R. 925 / H.R. 8406, The HEROES Act and The Health, Economic Assistance, Liability Protection and Schools (HEALS) Act.
Issues related to S. 1895, Lower Health Care Costs Act of 2019. H.R. 3630, No Surprises Act. H.R. 861, The End Surprise Billing Act. H.R. 3502, The Protecting People From Surprise Medical Bills Act. H.R. 5800, The Ban Surprise Medical Bill Act.
Protecting Patients Transportation to Care Act
Client: BLUEBIRD BIO · Firm: THE NICKLES GROUP, LLC
S. 2543 Prescription Drug Pricing Act and issues related to value based payment over time; H.R. 5882 Gene Therapy Payment Act; H.R. 3935, the Protecting Patients Transportation to Care Act; issues related to the Notice of Proposed rulemaking supporting VBP Arrangement; monitored issues related to H.R. 133, the Consolidated Appropriations Act of 2021; monitored issues related to the Most Favored Nation (MFN) rule.
Protecting Patients Transportation to Care Act
Client: BLUEBIRD BIO · Firm: THE NICKLES GROUP, LLC
Issues related to drug pricing including S. 2543 Prescription Drug pricing Act and issues related to value based payment over time; H.R. 5882 the GENE Therapy Payment Act; H.R. 3 Elijah E. Cummings lower drug costs act; issues related to Medicaid Best Price and AMP reporting. Issues related to H.R. 3935, the Protecting Patients Transportation to Care Act.
Protecting Patients Transportation to Care Act
Client: BLUEBIRD BIO · Firm: THE NICKLES GROUP, LLC
S. 2543 Prescription Drug Pricing Act and issues related to value based payment over time; H.R. 5882 Gene Therapy Payment Act; H.R. 3935, the Protecting Patients Transportation to Care Act; issues related to the Notice of Proposed rulemaking supporting VBP Arrangements.
Protecting Patients Transportation to Care Act
Client: BLUEBIRD BIO · Firm: THE NICKLES GROUP, LLC
S. 2543 Prescription Drug Pricing Act and issues related to value based payment over time; H.R. 5882 Gene Therapy Payment Act; H.R. 3935, the Protecting Patients Transportation to Care Act; issues related to the Notice of Proposed rulemaking supporting VBP Arrangement; issues related to the Executive Order on Lowering Drug Prices by Putting America First.
Monitored issues related to prescription drug prices; H.R. 5172, NOPAIN Act and S. 3067, Non-Opioids Prevent Addiction In the Nation Act and issues involving access to patients to non-opioid alternatives; issues related to outpatient reimbursement.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
JOHNSON & JOHNSON SERVICES, INC. via THE NICKLES GROUP, LLC
2020 · fourth_quarter · Q4
S. 2543, Prescription Drug Pricing Reduction Act of 2019, issues related to ASP reporting; issues related to Medicare coverage of vaccines; issues related to H.R. 133, the Consolidated Appropriations Act of 2021, including vaccines, ASP reporting and liability. Monitored issues related to Most Favored Nation (MFN) rule and drug rebates.
Monitored issues related to S. 1895, Lower Health Care Costs Act of 2019; monitored issues related to P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act); issues related to maternal mortality.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
UCB, INC. via THE NICKLES GROUP, LLC
2020 · fourth_quarter · Q4
Issues related to the implementation of P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act); issues related to the COVID-19 access to Part B drugs; issues related to the Most Favored Nation (MFN) and rebate rule; H.R. 133, the Consolidated Appropriations Act of 2021, issues related to reimbursement of self-administered drugs; issues related to the importation of prescription drugs.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BLUEBIRD BIO via THE NICKLES GROUP, LLC
2020 · fourth_quarter · Q4
Issues related to FDA approval of breakthrough therapies.
S. 2543 Prescription Drug Pricing Act and issues related to value based payment over time; H.R. 5882 Gene Therapy Payment Act; H.R. 3935, the Protecting Patients Transportation to Care Act; issues related to the Notice of Proposed rulemaking supporting VBP Arrangement; monitored issues related to H.R. 133, the Consolidated Appropriations Act of 2021; monitored issues related to the Most Favored Nation (MFN) rule.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CSL BEHRING LLC via THE NICKLES GROUP, LLC
2020 · fourth_quarter · 4A
Issues involving promoting plasma donation and convalescent plasma donation; issues involving the development hyperimmune globulin treatment; monitored issues related to H.R. 925 / H.R. 8406, The HEROES Act and The Health, Economic Assistance, Liability Protection and Schools (HEALS) Act; H.R. 8337, Continuing Appropriations Act, 2021 and Other Extensions Act; S. 4317, SAFE TO WORK Act; S. 4322, Safely Back to School and Back to Work Act. H.R. 133, the Consolidated Appropriations Act of 2021. Monitored S.AMDT 2562 to S. 178, Delivering Immediate Relief to Americas Families, Schools and Small Businesses Act.
Issues related to home infusion and DME self-administered therapies. Issues regarding coverage and reimbursement of biologics and plasma therapies. Monitored issues related to H.R. 2905, Medicare IVIG Access Enhancement Act. Monitored S. 2543, Prescription Drug Pricing Reduction Act of 2019. S. 3457 / H.R. 6218, Preserving Patient Access to Home Infusion Act, as it relates to access to drugs listed on the self-administered drug list. H.R. 7839, Continuing Access to In-Home IVIG Act. H.R. 133, the Consolidated Appropriations Act of 2021, including home infusion and DME self-administered therapies. Issues concerning the most favored nation rule as it relates to plasma-derived products.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CSL BEHRING LLC via THE NICKLES GROUP, LLC
2020 · fourth_quarter · 4A
Issues involving promoting plasma donation and convalescent plasma donation; issues involving the development hyperimmune globulin treatment; monitored issues related to H.R. 925 / H.R. 8406, The HEROES Act and The Health, Economic Assistance, Liability Protection and Schools (HEALS) Act; H.R. 8337, Continuing Appropriations Act, 2021 and Other Extensions Act; S. 4317, SAFE TO WORK Act; S. 4322, Safely Back to School and Back to Work Act. H.R. 133, the Consolidated Appropriations Act of 2021. Monitored S.AMDT 2562 to S. 178, Delivering Immediate Relief to Americas Families, Schools and Small Businesses Act.
Issues related to home infusion and DME self-administered therapies. Issues regarding coverage and reimbursement of biologics and plasma therapies. Monitored issues related to H.R. 2905, Medicare IVIG Access Enhancement Act. Monitored S. 2543, Prescription Drug Pricing Reduction Act of 2019. S. 3457 / H.R. 6218, Preserving Patient Access to Home Infusion Act, as it relates to access to drugs listed on the self-administered drug list. H.R. 7839, Continuing Access to In-Home IVIG Act. H.R. 133, the Consolidated Appropriations Act of 2021, including home infusion and DME self-administered therapies. Issues concerning the most favored nation rule as it relates to plasma-derived products.
AMERICAN HOSPITAL ASSOCIATION via THE NICKLES GROUP, LLC
2020 · fourth_quarter · 4A
H.R. 133, the Consolidated Appropriations Act of 2021, including issues related to sequestration relief, rural hospitals, provider relief funding and Medicaid DSH payments. Implementation of P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act).
H.R. 133, the Consolidated Appropriations Act of 2021, as it relates to provider relief fund and issues related to surprise medical billing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
ACCENTURE FEDERAL SERVICES LLC via THE NICKLES GROUP, LLC
2020 · fourth_quarter · Q4
Monitored issues related to the Affordable Care Act and the federal exchange; issues related to vaccines management. Monitored issues related to H.R. 133, the Consolidated Appropriations Act of 2021, as it relates to vaccines.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Indian Health Service, SENATE
SMITH & NEPHEW, INC. via THE NICKLES GROUP, LLC
2020 · fourth_quarter · Q4
H.R. 8624, Protecting Access to Innovation During COVID-19 Act; H.R. 7127, and issues related to disposable negative pressure wound therapy; issues related to telehealth; monitored implementation of P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act); monitored issues related to the Most Favored Nation (MFN) rule. H.R. 133, the Consolidated Appropriations Act of 2021, and issues related to health extenders.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BRISTOL-MYERS SQUIBB COMPANY via THE NICKLES GROUP, LLC
2020 · fourth_quarter · Q4
Most Favored Nation (MFN) rule & drug rebates; H.R. 133, the Consolidated Appropriations Act of 2021, issues related to COVID-19, and the reimbursement of self-administered drugs.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ORTHO-CLINICAL DIAGNOSTICS, INC. via THE NICKLES GROUP, LLC
2020 · fourth_quarter · Q4
Implementation issues related to P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act); funding issues related to antibody & antigen tests for COVID-19; H.R. 133, the Consolidated Appropriations Act of 2021, issues related to COVID testing.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
OMEROS CORPORATION via THE NICKLES GROUP, LLC
2020 · fourth_quarter · Q4
Monitored issues related to prescription drug prices; H.R. 5172, NOPAIN Act and S. 3067, Non-Opioids Prevent Addiction In the Nation Act and issues involving access to patients to non-opioid alternatives; issues related to the 2021 OPPS final rule; monitored issues related to H.R. 133, the Consolidated Appropriations Act of 2021.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MYRIAD GENETICS, INC. via THE NICKLES GROUP, LLC
2020 · fourth_quarter · Q4
S 3404, VALID Act and regulation of pharmacogenomic tests.
Issues related to laboratory developed tests and reimbursement; issues related to the implementation of P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act). Issues related to the 2020 OPPS rule specifically related to packaging policy. Monitored issues related to H.R. 133, the Consolidated Appropriations Act of 2021, as it relates to surprise medical billing. Issues related to provider relief fund.
Issues related to S. 3404, VALID Act. Monitored issues related to the implementation of P.L. 116-136., Coronavirus Aid, Response, and Economic Security Act (CARES Act). Issues related to S. 1895, the Lower Healthcare Cost Act including Surprise Medical Billing, issues related to H.R. 861, the End Surprise Billing Act, H.R. 5800, The Ban Surprise Billing Act; issues related to EKRA; H.R. 925 / H.R. 8406, The HEROES Act, issues related to COVID-19 testing and provider relief. H.R. 133, the Consolidated Appropriations Act of 2021, including surprise medical bill and COVID-19 testing.
SCAN HEALTH PLAN via THE NICKLES GROUP, LLC
2020 · fourth_quarter · Q4
H.R. 3461, Community-Based Independence for Seniors Act of 2019, issues related to Medicare advantage. Monitored implementation of P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act); issues related to telehealth; issues related to the Most Favored Nation (MFN) and drug rebate rule. H.R. 133, the Consolidated Appropriations Act of 2021, issues related to health extenders and telehealth.
H.R. 133, the Consolidated Appropriations Act of 2021, issues related to health extenders and telehealth.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
GILEAD SCIENCES, INC. via THE NICKLES GROUP, LLC
2020 · fourth_quarter · Q4
Issues related to the reimbursement of CAR-T therapy; monitored issues related to international drug pricing.
Monitored issues related to COVID relief including H.R. 925 / H.R. 8406, The HEROES Act. Monitored H.R. 133, the Consolidated Appropriations Act of 2021.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
CLEVELAND CLINIC FOUNDATION via THE NICKLES GROUP, LLC
2020 · fourth_quarter · Q4
Monitored issues related to drug pricing and drug shortages. Monitored issues related to price transparency. Monitored issues related to H.R. 3630, No Surprises Act, S. 1895, Lower Health Care Costs Act of 2019, H.R. 5800, Ban Surprise Billing Act, as it relates to surprise billing. Monitored S. 1399, Title VIII Nursing Workforce Reauthorization Act of 2019; S. 4317, SAFE TO WORK Act; S. 4322, Safely Back to School and Back to Work Act; issues related to H.R. 925 / H.R. 8406, The HEROES Act and The Health, Economic Assistance, Liability Protection and Schools (HEALS) Act. H.R. 8283, Temporary Reciprocity to Ensure Access to Treatment (TREAT) Act.
Monitored issues related to prescription drug pricing. Issues regarding telehealth. Issues regarding PPS exempt hospitals. Issues regarding price transparency. H.R. 8337, Continuing Appropriations Act, 2021 and Other Extensions Act, as it relates to accelerated payments and Medicaid DSH. H.R. 7791, Value in Health Care Act of 2020. Implementation of P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act), as it relates to provider funding. H.R. 133, The Consolidated Appropriations Act of 2021 including provider relief funding, Medicaid DSH, surprise billing, sequestration relief, testing, vaccines and liability reform.
ACCENTURE LLP via THE NICKLES GROUP, LLC
2020 · fourth_quarter · Q4
H.R. 925 / H.R. 8406, The HEROES Act, S. 4317 the SAFE to WORK Act, S. Amdt. 2652 to S. 178, Delivering Immediate Relief to Americas Families, Schools and Small Businesses Act, H.R. 133, the Consolidated Appropriations Act of 2021, as they relate to COVID liability relief.
Monitored issues related to surprise medical billing. S. 4320, Coronavirus Response Additional Supplemental Appropriations Act; H.R. 925 / H.R. 8406, The HEROES Act; and S. Amdt. 2652 to S. 178, Delivering Immediate Relief to Americas Families, Schools and Small Businesses Act, as they relate to contact tracing and testing for COVID-19.
Filing targets: Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Office of Management & Budget (OMB), SENATE
GUARDANT HEALTH via THE NICKLES GROUP, LLC
2020 · fourth_quarter · 4T
Monitored issues related to the regulation of laboratory developed tests and the VALID Act. Monitored H.R. 1765, Donald Payne Sr. Colorectal Cancer Detection Act of 2019. Monitored implementation of P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act). Issues related to P.L. 115-271, The SUPPORT Act; monitored issues related to H.R. 133, the Consolidated Appropriations Act of 2021.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CSL BEHRING LLC via THE NICKLES GROUP, LLC
2020 · fourth_quarter · 4A
Issues related to home infusion and DME self-administered therapies. Issues regarding coverage and reimbursement of biologics and plasma therapies. Monitored issues related to H.R. 2905, Medicare IVIG Access Enhancement Act. Monitored S. 2543, Prescription Drug Pricing Reduction Act of 2019. S. 3457 / H.R. 6218, Preserving Patient Access to Home Infusion Act, as it relates to access to drugs listed on the self-administered drug list. H.R. 7839, Continuing Access to In-Home IVIG Act. H.R. 133, the Consolidated Appropriations Act of 2021, including home infusion and DME self-administered therapies. Issues concerning the most favored nation rule as it relates to plasma-derived products.
Issues involving promoting plasma donation and convalescent plasma donation; issues involving the development hyperimmune globulin treatment; monitored issues related to H.R. 925 / H.R. 8406, The HEROES Act and The Health, Economic Assistance, Liability Protection and Schools (HEALS) Act; H.R. 8337, Continuing Appropriations Act, 2021 and Other Extensions Act; S. 4317, SAFE TO WORK Act; S. 4322, Safely Back to School and Back to Work Act. H.R. 133, the Consolidated Appropriations Act of 2021. Monitored S.AMDT 2562 to S. 178, Delivering Immediate Relief to Americas Families, Schools and Small Businesses Act.
AMERICAN HOSPITAL ASSOCIATION via THE NICKLES GROUP, LLC
2020 · fourth_quarter · Q4
H.R. 133, the Consolidated Appropriations Act of 2021, including issues related to sequestration relief, rural hospitals, provider relief funding and Medicaid DSH payments. Implementation of P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act).
H.R. 133, the Consolidated Appropriations Act of 2021, as it relates to provider relief fund and issues related to surprise medical billing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
AMERICAN SOCIETY OF ANESTHESIOLOGISTS via THE NICKLES GROUP, LLC
2020 · fourth_quarter · Q4
Issues related to drug shortages.
Issues related to rural anesthesiology; issues related to scope of practice; issues related to implementation of P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act); issues related to COVID-19 in anesthesiology; H.R. 133, the Consolidated Appropriations Act of 2021, as it relates to COVID relief and surprise medical billing.
Issues pertaining to administration of anesthesia services for veterans.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
CSL BEHRING LLC via THE NICKLES GROUP, LLC
2020 · fourth_quarter · Q4
Issues involving promoting plasma donation and convalescent plasma donation; issues involving the development hyperimmune globulin treatment; monitored issues related to H.R. 925 / H.R. 8406, The HEROES Act and The Health, Economic Assistance, Liability Protection and Schools (HEALS) Act; H.R. 8337, Continuing Appropriations Act, 2021 and Other Extensions Act; S. 4317, SAFE TO WORK Act; S. 4322, Safely Back to School and Back to Work Act. H.R. 133, the Consolidated Appropriations Act of 2021. Monitored S.AMDT 2562 to S. 178, Delivering Immediate Relief to Americas Families, Schools and Small Businesses Act.
Issues related to home infusion and DME self-administered therapies. Issues regarding coverage and reimbursement of biologics and plasma therapies. Monitored issues related to H.R. 2905, Medicare IVIG Access Enhancement Act. Monitored S. 2543, Prescription Drug Pricing Reduction Act of 2019. S. 3457 / H.R. 6218, Preserving Patient Access to Home Infusion Act, as it relates to access to drugs listed on the self-administered drug list. H.R. 7839, Continuing Access to In-Home IVIG Act. H.R. 133, the Consolidated Appropriations Act of 2021, including home infusion and DME self-administered therapies. Issues concerning the most favored nation rule as it relates to plasma-derived products.
MANAGEMENT HEALTH SYSTEMS, LLC (D/B/A MEDPRO) via THE NICKLES GROUP, LLC
2020 · fourth_quarter · Q4
H.R. 6788 / S.3599 Healthcare Workforce Resilience Act.
Filing targets: HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE
SIDECAR HEALTH, INC. via THE NICKLES GROUP, LLC
2020 · fourth_quarter · Q4
Issues related to consumer directed healthcare and expanded access.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS)
CIGNA CORPORATION via THE NICKLES GROUP, LLC
2020 · fourth_quarter · Q4
H.R. 7839, Continuing Access to In-Home IVIG Act. Monitored issues related to H.R. 133, the Consolidated Appropriations Act of 2021 / PL 116-260 - FY2021 Omnibus and COVID Relief and Response Act, including access to IVIG and telehealth. Issues related to Medicare Advantage plans.
Issues related to S.1895, the Lower Health Care Costs Act of 2019, and issues related to transparency. Issues related to H.R. 133, the Consolidated Appropriations Act of 2021 / PL 116-260 - FY2021 Omnibus and COVID Relief and Response Act, including COVID-19 testing and surprise medical billing.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
UCB, INC. via THE NICKLES GROUP, LLC
2020 · third_quarter · Q3
Issues related to the implementation of P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act); issues related to the COVID-19 access to Part B drugs; issues related to the Executive Order on Lowering Drug Prices by Putting America First; issues related to the importation of prescription drugs.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
JOHNSON & JOHNSON SERVICES, INC. via THE NICKLES GROUP, LLC
2020 · third_quarter · Q3
Monitored issues related to S. 1895, Lower Health Care Costs Act of 2019; monitored issues related to P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act); issues related to maternal mortality; H.R. 925 / H.R. 8406, The HEROES Act and The Health, Economic Assistance, Liability Protection and Schools (HEALS) Act and issues related to vaccines and liability; issues related to the Executive Order on Lowering Drug Prices by Putting America First.
Monitored issues related to H.R. 7120, the George Floyd Justice in Policing Act, and S. 3985, the JUSTICE Act.
GILEAD SCIENCES, INC. via THE NICKLES GROUP, LLC
2020 · third_quarter · Q3
Issues related to the reimbursement of CAR-T therapy and the 2020 IPPS proposed rule; monitored issues related to international drug pricing.
Monitored issues related to the The Health, Economic Assistance, Liability Protection and Schools (HEALS) Act; monitored issues related to COVID relief including H.R. 925 / H.R. 8406, The HEROES Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
BLUEBIRD BIO via THE NICKLES GROUP, LLC
2020 · third_quarter · Q3
S. 2543 Prescription Drug Pricing Act and issues related to value based payment over time; H.R. 5882 Gene Therapy Payment Act; H.R. 3935, the Protecting Patients Transportation to Care Act; issues related to the Notice of Proposed rulemaking supporting VBP Arrangement; issues related to the Executive Order on Lowering Drug Prices by Putting America First.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN HOSPITAL ASSOCIATION via THE NICKLES GROUP, LLC
2020 · third_quarter · Q3
Issues related to S. 1895, Lower Health Care Costs Act of 2019. H.R. 3630, No Surprises Act. H.R. 861, The End Surprise Billing Act. H.R. 3502, The Protecting People From Surprise Medical Bills Act. H.R. 5800, The Ban Surprise Medical Bill Act.
Monitored issues related to price transparency; issues related to rural hospitals; issues related to Medicaid DSH payments; implementation of P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act). Issues related to H.R. 925 / H.R. 8406, The HEROES Act and The Health, Economic Assistance, Liability Protection and Schools (HEALS) Act. H.R. 8337, Continuing Appropriations Act, 2021 and Other Extensions Act.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Occupational Safety & Health Administration (OSHA), SENATE, White House Office
ACCENTURE LLP via THE NICKLES GROUP, LLC
2020 · third_quarter · Q3
H.R. 925 / H.R. 8406, The HEROES Act, S. 4317 the SAFE to WORK Act, S. Amdt. 2652 to S. 178, Delivering Immediate Relief to Americas Families, Schools and Small Businesses Act, as they relate to COVID liability relief.
Monitored issues related to surprise medical billing. S. 4320, Coronavirus Response Additional Supplemental Appropriations Act; H.R. 925 / H.R. 8406, The HEROES Act; and S. Amdt. 2652 to S. 178, Delivering Immediate Relief to Americas Families, Schools and Small Businesses Act, as they relate to contact tracing and testing for COVID-19.
Filing targets: Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE
BRISTOL-MYERS SQUIBB COMPANY via THE NICKLES GROUP, LLC
2020 · third_quarter · Q3
Issues related to the reimbursement of CAR-T therapy; issues related to the Executive Order on Lowering Drug Prices by Putting America First.
Monitored issues related to H.R. 925 / H.R. 8406, The HEROES Act and The Health, Economic Assistance, Liability Protection and Schools (HEALS) Act; issues related to prescription drug research and development and product life cycles; H.R. 8337, Continuing Appropriations Act, 2021 and Other Extensions Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
CIGNA CORPORATION via THE NICKLES GROUP, LLC
2020 · third_quarter · 3A
Issues related to Medicare Advantage and issues related to price transparency. Issues related to the Executive Order on Lowering Drug Prices by Putting America First. Issues related to H.R. 7839, Continuing Access to In Home IVIG Act.
Monitored issues related to surprise medical bills including H.R 3502, H.R. 861, H.R. 3630, H.R 2328; issues related to S.1895 the Lower Health Care Costs Act of 2019 and issues related to transparency; implementation issues related to P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act); issues related to COBRA subsidies. The Health, Economic Assistance, Liability Protection and Schools (HEALS) Act and H.R. 925/H.R. 8406, The HEROES Act and issues related to COVID-19 testing.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
CLEVELAND CLINIC FOUNDATION via THE NICKLES GROUP, LLC
2020 · third_quarter · Q3
Monitored issues related to drug pricing and drug shortages. Monitored issues related to price transparency. Monitored issues related to H.R. 3630, No Surprises Act, S. 1895, Lower Health Care Costs Act of 2019, H.R. 5800, Ban Surprise Billing Act, as it relates to surprise billing. Monitored S. 1399, Title VIII Nursing Workforce Reauthorization Act of 2019; S. 4317, SAFE TO WORK Act; S. 4322, Safely Back to School and Back to Work Act; issues related to H.R. 925 / H.R. 8406, The HEROES Act and The Health, Economic Assistance, Liability Protection and Schools (HEALS) Act.
Monitored issues related to prescription drug pricing. Issues related to CAR T-cell therapy reimbursement. Issues regarding telehealth. Issues regarding PPS exempt hospitals. Issues regarding price transparency. H.R. 8337, Continuing Appropriations Act, 2021 and Other Extensions Act, as it relates to accelerated payments and Medicaid DSH. H.R. 7791, Value in Health Care Act of 2020. Implementation of P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act), as it relates to provider funding.
CIGNA CORPORATION via THE NICKLES GROUP, LLC
2020 · third_quarter · Q3
Issues related to Medicare Advantage and issues related to price transparency. Issues related to the Executive Order on Lowering Drug Prices by Putting America First. Issues related to H.R. 7839, Continuing Access to In Home IVIG Act.
Monitored issues related to surprise medical bills including H.R 3502, H.R. 861, H.R. 3630, H.R 2328; issues related to S.1895 the Lower Health Care Costs Act of 2019 and issues related to transparency; implementation issues related to P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act); issues related to COBRA subsidies. The Health, Economic Assistance, Liability Protection and Schools (HEALS) Act and H.R. 925/H.R. 8406, The HEROES Act and issues related to testing.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
ACCENTURE FEDERAL SERVICES LLC via THE NICKLES GROUP, LLC
2020 · third_quarter · Q3
Monitored issues related to the Affordable Care Act and the federal exchange; issues related to HRSA; issues related to telehealth.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Indian Health Service, SENATE
CSL BEHRING LLC via THE NICKLES GROUP, LLC
2020 · third_quarter · Q3
Issues involving promoting plasma donation and convalescent plasma donation; issues involving the development hyperimmune globulin treatment; monitored issues related to H.R. 925 / H.R. 8406, The HEROES Act and The Health, Economic Assistance, Liability Protection and Schools (HEALS) Act; H.R. 8337, Continuing Appropriations Act, 2021 and Other Extensions Act; S. 4317, SAFE TO WORK Act; S. 4322, Safely Back to School and Back to Work Act.
Issues related to home infusion and DME self-administered therapies. Issues regarding coverage and reimbursement of biologics and plasma therapies. Monitored issues related to H.R. 2905, Medicare IVIG Access Enhancement Act. Monitored S. 2543, Prescription Drug Pricing Reduction Act of 2019. S. 3457 / H.R. 6218, Preserving Patient Access to Home Infusion Act, as it relates to access to drugs listed on the self-administered drug list. Issues related to the Executive Order on Lowering Drug Prices by Putting America First. H.R. 7839, Continuing Access to In-Home IVIG Act.
SCAN HEALTH PLAN via THE NICKLES GROUP, LLC
2020 · third_quarter · Q3
H.R. 925 / H.R. 8406, The HEROES Act and The Health, Economic Assistance, Liability Protection and Schools (HEALS) Act, as it relates to providers and health plans.
H.R. 3461, Community-Based Independence for Seniors Act of 2019, issues related to Medicare advantage. Monitored implementation of P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act); issues related to telehealth; issues related to the Executive Order on Lowering Drug Prices by Putting America First.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
SMITH & NEPHEW, INC. via THE NICKLES GROUP, LLC
2020 · third_quarter · Q3
Monitored issues related H.R. 925 / H.R. 8406, The HEROES Act and The Health, Economic Assistance, Liability Protection and Schools (HEALS) Act; H.R. 8337, Continuing Appropriations Act, 2021 and Other Extensions Act.
Issues related to drug pricing and pass through payment; issues related to disposable negative pressure wound therapy; issues related to telehealth; monitored implementation of P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act); issues related to the Executive Order on Lowering Drug Prices by Putting America First.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN SOCIETY OF ANESTHESIOLOGISTS via THE NICKLES GROUP, LLC
2020 · third_quarter · Q3
Issues pertaining to administration of anesthesia services for veterans; issues related to the Executive Order on Lowering Drug Prices by Putting America First.
Issues related to rural anesthesiology; issues related to scope of practice; issues related to P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act); issues related to COVID-19 in anesthesiology.
Issues related to drug shortages; issues related to scope of practice; S. 1895, Lower Health Care Costs Act of 2019; H.R. 861, End Surprise Billing Act of 2019; H.R. 3630, No Surprises Act; H.R. 3502, Protecting People from Surprise Medical Bills Act. P.L. 116-136., Coronavirus Aid, Response, and Economic Security Act (CARES Act). Issues related to H.R. 925 / H.R. 8406, The HEROES Act and The Health, Economic Assistance, Liability Protection and Schools (HEALS) Act.
OMEROS CORPORATION via THE NICKLES GROUP, LLC
2020 · third_quarter · Q3
Monitored issues related to prescription drug prices; H.R. 5172, NOPAIN Act and S. 3067, Non-Opioids Prevent Addiction In the Nation Act and issues involving access to patients to non-opioid alternatives; issues related to outpatient reimbursement.
Monitored H.R. 925 / H.R. 8406, The HEROES Act and The Health, Economic Assistance, Liability Protection and Schools (HEALS) Act; monitored H.R. 8337, Continuing Appropriations Act, 2021 and Other Extensions Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MYRIAD GENETICS, INC. via THE NICKLES GROUP, LLC
2020 · third_quarter · Q3
Issues related to laboratory developed tests and reimbursement; issues related to the implementation of P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act).
Issues related to S. 3404, VALID Act. Monitored issues related to the implementation of P.L. 116-136., Coronavirus Aid, Response, and Economic Security Act (CARES Act). Issues related to S. 1895, the Lower Healthcare Cost Act including Surprise Medical Billing, issues related to H.R. 861, the End Surprise Billing Act, H.R. 5800, The Ban Surprise Billing Act; issues related to EKRA; H.R. 925 / H.R. 8406, The HEROES Act and The Health, Economic Assistance, Liability Protection and Schools (HEALS) Act, issues related to COVID-19 testing and provider relief.
GUARDANT HEALTH via THE NICKLES GROUP, LLC
2020 · third_quarter · Q3
Monitored issues related to the regulation of laboratory developed tests and the VALID Act; issues related to liquid biopsy; S. 1895, Lower Health Care Costs Act of 2019; H.R. 861, End Surprise Billing Act of 2019. Monitored H.R. 1765, Donald Payne Sr. Colorectal Cancer Detection Act of 2019. P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act). Issues related to P.L. 115-271, The SUPPORT Act; H.R. 925 / H.R. 8406, The HEROES Act and The Health, Economic Assistance, Liability Protection and Schools (HEALS) Act, related to COVID testing.
Issues related to the 2020 Hospital Outpatient Prospective Payment proposed rule and the Laboratory Date of Service Policy.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ORTHO-CLINICAL DIAGNOSTICS, INC. via THE NICKLES GROUP, LLC
2020 · third_quarter · Q3
Implementation of issues related to P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act); funding issues related to antibody & antigen tests for COVID-19; H.R. 925 / H.R. 8406, The HEROES Act and The Health, Economic Assistance, Liability Protection and Schools (HEALS) Act, issues related to COVID testing.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Executive Office of the President (EOP), Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
MANAGEMENT HEALTH SYSTEMS, LLC (D/B/A MEDPRO) via THE NICKLES GROUP, LLC
2020 · third_quarter · Q3
H.R. 6788 / S.3599 Healthcare Workforce Resilience Act.
Filing targets: HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE
AMERICAN TRUCKING ASSOCIATIONS via THE NICKLES GROUP, LLC
2020 · third_quarter · 3T
Issues related to hair testing.
Filing targets: Executive Office of the President (EOP), Office of Management & Budget (OMB)
SIDECAR HEALTH, INC. via THE NICKLES GROUP, LLC
2020 · third_quarter · Q3
Issues related to consumer-directed health care coverage.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS)
SEND RELIEF, INC. via THE NICKLES GROUP, LLC
2020 · first_quarter · 1A
Issues related to disaster relief and Covid-19.
Filing targets: Executive Office of the President (EOP), Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE
AMERICAN HOSPITAL ASSOCIATION via THE NICKLES GROUP, LLC
2020 · second_quarter · Q2
Monitored issues related to price transparency; issues related to rural hospitals; issues related to Medicaid DSH payments; implementation of P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act). S. 2543, The Prescription Drug Pricing Reduction Act of 2019.
Issues related to S. 1895, Lower Health Care Costs Act of 2019. H.R. 3630, No Surprises Act. H.R. 861, The End Surprise Billing Act. H.R. 3502, The Protecting People From Surprise Medical Bills Act. H.R. 5800, The Ban Surprise Medical Bill Act.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Occupational Safety & Health Administration (OSHA), SENATE, White House Office
SEND RELIEF, INC. via THE NICKLES GROUP, LLC
2020 · second_quarter · 2T
Issues related to disaster relief and Covid-19.
Filing targets: Executive Office of the President (EOP), Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE
SCAN HEALTH PLAN via THE NICKLES GROUP, LLC
2020 · second_quarter · Q2
H.R. 3461, Community-Based Independence for Seniors Act of 2019, issues related to Medicare advantage. Monitored implementation of P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act); issues related to telehealth.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
CSL BEHRING LLC via THE NICKLES GROUP, LLC
2020 · second_quarter · Q2
Issues related to home infusion and DME self-administered therapies. Issues regarding coverage and reimbursement of biologics and plasma therapies. Issues pertaining to drugs listed on the Self-Administered Drug list. Monitored issues related to H.R. 2905, Medicare IVIG Access Enhancement Act. Monitored S. 2543, Prescription Drug Pricing Reduction Act of 2019. S. 3457 / H.R. 6218, Preserving Patient Access to Home Infusion Act, as it relates to access to drugs listed on the self-administered drug list. Monitored issues related to drug pricing. Issues related to the corona virus.
Monitored issues related to prescription drug pricing. Monitored S. 1895, Lower Health Care Costs Act of 2019, as it relates to pricing transparency and drug pricing. Issues involving promoting plasma donation and convalescent plasma donation.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE
ACCENTURE LLP via THE NICKLES GROUP, LLC
2020 · second_quarter · Q2
Monitored issues related to surprise medical billing. Issues related to contact tracing and testing for COVID-19.
Filing targets: Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, SENATE
CLEVELAND CLINIC FOUNDATION via THE NICKLES GROUP, LLC
2020 · second_quarter · Q2
Issues regarding proposals to reduce health care costs; monitored issues related to drug pricing and drug shortages. Issues related to H.R. 1309, Workplace Violence Prevention for Health Care and Social Service Workers Act. Monitored issues related to price transparency. Monitored issues related to H.R. 3630, No Surprises Act, S. 1895, Lower Health Care Costs Act of 2019, H.R. 5800, Ban Surprise Billing Act, as it relates to surprise billing. Monitored S. 1399, Title VIII Nursing Workforce Reauthorization Act of 2019.
Monitored issues related to prescription drug pricing. Issues related to CAR T-cell therapy reimbursement. Issues regarding telehealth. Issues regarding PPS exempt hospitals. Issues regarding price transparency. Issues related to the coronavirus.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of the Vice President of the United States, SENATE
ORTHO-CLINICAL DIAGNOSTICS, INC. via THE NICKLES GROUP, LLC
2020 · second_quarter · Q2
Implementation of issues related to P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act); issues related to antibody tests for COVID-19.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
SMITH & NEPHEW, INC. via THE NICKLES GROUP, LLC
2020 · second_quarter · Q2
Monitored issues related to the regulation of medical devices.
Monitored issues related to drug pricing; issues related to disposable negative pressure wound therapy; S. 2543, Prescription Drug Pricing Reduction Act of 2019; issues related to telehealth; monitored implementation of P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MYRIAD GENETICS, INC. via THE NICKLES GROUP, LLC
2020 · second_quarter · Q2
Issues related to laboratory developed tests and reimbursement; issues related to the implementation of P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act).
S 3404, VALID Act and regulation of pharmcogenomic tests.
Issues related to S. 3404, VALID Act. Monitored issues related to the implementation of P.L. 116-136., Coronavirus Aid, Response, and Economic Security Act (CARES Act). Issues related to S. 1895, the Lower Healthcare Cost Act including Surprise Medical Billing, issues related to H.R. 861, the End Surprise Billing Act, H.R. 5800, The Ban Surprise Billing Act; issues related to EKRA.
BRISTOL-MYERS SQUIBB COMPANY via THE NICKLES GROUP, LLC
2020 · second_quarter · Q2
Issues related to S. 2543, The Prescription Drug Pricing Reduction Act of 2019 and including Part D and Part B; issues related to the reimbursement of CAR-T therapy; issues related to foreign drug pricing.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
AMERICAN SOCIETY OF ANESTHESIOLOGISTS via THE NICKLES GROUP, LLC
2020 · second_quarter · Q2
Issues pertaining to administration of anesthesia services for veterans.
Issues related to rural anesthesiology; issues related to scope of practice; issues related to P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act); issues related to COVID-19 in anesthesiology.
Issues related to drug shortages; issues related to scope of practice; S. 1895, Lower Health Care Costs Act of 2019; H.R. 861, End Surprise Billing Act of 2019; H.R. 3630, No Surprises Act; H.R. 3502, Protecting People from Surprise Medical Bills Act. P.L. 116-136., Coronavirus Aid, Response, and Economic Security Act (CARES Act).
GILEAD SCIENCES, INC. via THE NICKLES GROUP, LLC
2020 · second_quarter · Q2
Issues related to the reimbursement of CAR-T therapy and the 2020 IPPS proposed rule.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
ACCENTURE FEDERAL SERVICES LLC via THE NICKLES GROUP, LLC
2020 · second_quarter · Q2
Monitored issues related to the Affordable Care Act and the federal exchange; issues related to HRSA.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MANAGEMENT HEALTH SYSTEMS, LLC (D/B/A MEDPRO) via THE NICKLES GROUP, LLC
2020 · second_quarter · Q2
H.R. 6788 / S.3599 Healthcare Workforce Resilience Act.
Issues related to nursing visas and H1-B visas.
Filing targets: HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE
CIGNA CORPORATION via THE NICKLES GROUP, LLC
2020 · second_quarter · Q2
Monitored issues related to surprise medical bills including H.R 3502, H.R. 861, H.R. 3630, H.R 2328; issues related to S.1895 the Lower Health Care Costs Act of 2019 and issues related to transparency; implementation issues related to P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act); issues related to COBRA subsidies.
Issues related to Medicare Advantage and issues related to price transparency.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BLUEBIRD BIO via THE NICKLES GROUP, LLC
2020 · second_quarter · Q2
S. 2543 Prescription Drug Pricing Act and issues related to value based payment over time; H.R. 5882 Gene Therapy Payment Act; H.R. 3935, the Protecting Patients Transportation to Care Act; issues related to the Notice of Proposed rulemaking supporting VBP Arrangements.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
JOHNSON & JOHNSON SERVICES, INC. via THE NICKLES GROUP, LLC
2020 · second_quarter · Q2
Issues related to drug pricing; monitored issues related to S. 1895, Lower Health Care Costs Act of 2019; monitored issues related to P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act); issues related to maternal mortality; issues related to vaccines and liability.
Monitored issues related to biosimilars; S. 2543, Prescription Drug Pricing Reduction Act of 2019, issues related to ASP reporting.
Monitored issues related to H.R. 7120, the George Floyd Justice in Policing Act, and S. 3985, the JUSTICE Act.
GUARDANT HEALTH via THE NICKLES GROUP, LLC
2020 · second_quarter · Q2
Issues related to the 2020 Hospital Outpatient Prospective Payment proposed rule and the Laboratory Date of Service Policy.
Monitored issues related to the regulation of laboratory developed tests and the VALID Act; issues related to liquid biopsy; S. 1895, Lower Health Care Costs Act of 2019; H.R. 861, End Surprise Billing Act of 2019. Monitored H.R. 1765, Donald Payne Sr. Colorectal Cancer Detection Act of 2019. P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act). Issues related to P.L. 115-271, The SUPPORT Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
OMEROS CORPORATION via THE NICKLES GROUP, LLC
2020 · second_quarter · Q2
Monitored issues related to prescription drug prices; H.R. 5172, NOPAIN Act and S. 3067, Non-Opioids Prevent Addiction In the Nation Act and issues involving access to patients to non-opioid alternatives; issues related to outpatient reimbursement.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
UCB, INC. via THE NICKLES GROUP, LLC
2020 · second_quarter · Q2
S. 2543, Prescription Drug Pricing Reduction Act of 2019 and issues related to the reimbursement of Part B and D drugs; issues related to the implementation of P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act); issues related to the COVID-19 access to Part B drugs.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
AMERICAN TRUCKING ASSOCIATIONS via THE NICKLES GROUP, LLC
2020 · second_quarter · Q2
Issues related to hair testing.
Filing targets: Executive Office of the President (EOP), Office of Management & Budget (OMB)
SIDECAR HEALTH, INC. via THE NICKLES GROUP, LLC
2020 · second_quarter · Q2
Issues related to consumer-directed health care coverage.
Filing targets: Health & Human Services, Dept of (HHS)
ORTHO-CLINICAL DIAGNOSTICS, INC. via THE NICKLES GROUP, LLC
2020 · second_quarter · RR
Issues related to COVID-19 and antibody testing.
EDITAS MEDICINE via THE NICKLES GROUP, LLC
2020 · second_quarter · 2T
Issues related to reimbursement of novel therapies; monitored issue related to drug pricing; S. 2543, Prescription Drug Pricing Reduction Act of 2019.
Issues related to the science of gene editing; issues related to the Agriculture Appropriations legislation.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MANAGEMENT HEALTH SYSTEMS, LLC (D/B/A MEDPRO) via THE NICKLES GROUP, LLC
2020 · first_quarter · Q1
Issues related to nursing visas.
Filing targets: Homeland Security, Dept of (DHS), SENATE
CLEVELAND CLINIC FOUNDATION via THE NICKLES GROUP, LLC
2020 · first_quarter · Q1
Monitored issues related to prescription drug pricing. Issues related to CAR T-cell therapy reimbursement. Issues regarding telehealth. Issues regarding PPS exempt hospitals. Issues regarding price transparency. Issues related to P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act).
Issues regarding proposals to reduce health care costs; monitored issues related to drug pricing and drug shortages. Issues related to H.R. 1309, Workplace Violence Prevention for Health Care and Social Service Workers Act. Monitored issues related to price transparency. Monitored issues related to H.R. 3630, No Surprises Act, S. 1895, Lower Health Care Costs Act of 2019, H.R. 5800, Ban Surprise Billing Act, as it relates to surprise billing. Monitored S. 1399, Title VIII Nursing Workforce Reauthorization Act of 2019.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of the Vice President of the United States, SENATE
ACCENTURE LLP via THE NICKLES GROUP, LLC
2020 · first_quarter · Q1
Monitored issues regarding workforce training programs.
Monitored issues related to surprise medical billing.
Monitor issues related to infrastructure financing. Monitor HR 748, the CARES Act, as it related to corporate tax relief.
Filing targets: Federal Emergency Management Agency (FEMA)
AMERICAN HOSPITAL ASSOCIATION via THE NICKLES GROUP, LLC
2020 · first_quarter · Q1
P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act).
Monitored issues related to price transparency; issues related to rural hospitals; issues related to Medicaid DSH payments; H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act. P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act). S. 2543, The Prescription Drug Pricing Reduction Act of 2019.
Issues related to 42 CFR Part 2; monitored issues regarding drug pricing; issues related to S. 1895, Lower Health Care Costs Act of 2019. H.R. 1309, Workplace Violence Prevention for Health Care and Social Service Workers Act. H.R. 3630, No Surprises Act. H.R. 861, The End Surprise Billing Act. H.R. 3502, The Protecting People From Surprise Medical Bills Act. H.R. 5800, The Ban Surprise Medical Bill Act. P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act).
CSL BEHRING LLC via THE NICKLES GROUP, LLC
2020 · first_quarter · Q1
Monitored issues related to prescription drug pricing. H.R. 2296, the METRIC Act. Monitored S. 1895, Lower Health Care Costs Act of 2019, as it relates to pricing transparency and drug pricing. H.R. 2113, Prescription Drug STAR Act.
Issues related to home infusion and DME self-administered therapies. Issues regarding coverage and reimbursement of biologics and plasma therapies. Issues pertaining to drugs listed on the Self-Administered Drug list. H.R. 2296, the METRIC Act. Monitored issues related to H.R. 2905, Medicare IVIG Access Enhancement Act. H.R. 2113, Prescription Drug STAR Act. Monitored S. 2543, Prescription Drug Pricing Reduction Act of 2019. H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act. S. 3457 / H.R. 6218, Preserving Patient Access to Home Infusion Act, as it relates to access to drugs listed on the self-administered drug list. Monitored Coronavirus Aid, Relief and Economic Security "CARES Act," P.L. 116-136.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
EDITAS MEDICINE via THE NICKLES GROUP, LLC
2020 · first_quarter · Q1
Issues related to the science of gene editing; issues related to the Agriculture Appropriations legislation.
Issues related to reimbursement of novel therapies; monitored issue related to drug pricing; S. 2543, Prescription Drug Pricing Reduction Act of 2019.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
METROPOLITAN LIFE INSURANCE COMPANY via THE NICKLES GROUP, LLC
2020 · first_quarter · 1T
Issues related to the implementation of The Tax Cut and Jobs Act, in particular the taxation of insurance and the taxation of foreign earnings of U.S. multinational corporations. S. 972, the Retirement Enhancement and Savings Act of 2019 and H.R. 1994, the SECURE Act, as they relate to employer pensions plans. Issues related to the Health Insurance Tax.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BRISTOL-MYERS SQUIBB COMPANY via THE NICKLES GROUP, LLC
2020 · first_quarter · Q1
Issues related to S. 1895, Lower Health Care Costs Act of 2019. Monitored issues related to P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act).
Issues related to S. 2543, The Prescription Drug Pricing Reduction Act of 2019 and including Part D and Part B; issues related to the IPI CMMI demonstration; monitored issues related to H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act; issues related to the reimbursement of CAR-T therapy.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SMITH & NEPHEW, INC. via THE NICKLES GROUP, LLC
2020 · first_quarter · Q1
Issues related to unique device identifiers; monitored issues related to drug pricing; issues related to disposable negative pressure wound therapy; S. 2543, Prescription Drug Pricing Reduction Act of 2019; H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act.
Issues related to implementation of the Tax Cut and Jobs Act regarding interest expensing; P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act).
Issues related to unique device identifiers; monitored issues related to the regulation of medical devices. Monitored H.R. 2113, Prescription Drug STAR Act, as it relates to sample device products.
SIDECAR HEALTH, INC. via THE NICKLES GROUP, LLC
2020 · first_quarter · Q1
Issues related to transparency and consumer-directed health care coverage. P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act).
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
UCB, INC. via THE NICKLES GROUP, LLC
2020 · first_quarter · Q1
Issues related to S. 1895, Lower Health Care Costs Act of 2019.
S. 2543, Prescription Drug Pricing Reduction Act of 2019 and issues related to the reimbursement of Part B and D drugs; and H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act. P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act).
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
SCAN HEALTH PLAN via THE NICKLES GROUP, LLC
2020 · first_quarter · Q1
H.R. 3461, Community-Based Independence for Seniors Act of 2019, issues related to Medicare advantage. P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act).
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
OMEROS CORPORATION via THE NICKLES GROUP, LLC
2020 · first_quarter · Q1
Monitored issues related to prescription drug prices; issues related to the Merit-Based Incentive Payment System (MIPS); H.R. 5172, NOPAIN Act and S. 3067, Non-Opioids Prevent Addiction In the Nation Act and issues involving access to patients to non-opioid alternatives.
Issues related to opioids. P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act).
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MYRIAD GENETICS, INC. via THE NICKLES GROUP, LLC
2020 · first_quarter · Q1
Issues related to laboratory developed tests and reimbursement.
Issues related to regulation of pharmcogenomic tests.
Issues related to the VALID Act. P.L. 116-136., Coronavirus Aid, Response, and Economic Security Act (CARES Act). Issues related to S. 1895, the Lower Healthcare Cost Act including Surprise Medical Billing, issues related to H.R. 861, the End Surprise Billing Act, H.R. 5800, The Ban Surprise Billing Act.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GUARDANT HEALTH via THE NICKLES GROUP, LLC
2020 · first_quarter · Q1
Monitored issues related to the regulation of laboratory developed tests and the VALID Act; issues related to liquid biopsy; S. 1895, Lower Health Care Costs Act of 2019; H.R. 861, End Surprise Billing Act of 2019. Monitored H.R. 1765, Donald Payne Sr. Colorectal Cancer Detection Act of 2019. P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act). Issues related to P.L. 115-271, The SUPPORT Act.
Issues related to the 2020 Hospital Outpatient Prospective Payment proposed rule and the Laboratory Date of Service Policy.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GILEAD SCIENCES, INC. via THE NICKLES GROUP, LLC
2020 · first_quarter · Q1
Issues related to the reimbursement of CAR-T therapy; monitored issues related to S. 2543, Prescription Drug Pricing Reduction Act of 2019 and H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
CIGNA CORPORATION via THE NICKLES GROUP, LLC
2020 · first_quarter · Q1
Monitored issues related to the safe harbor protection. S. 2543 The Prescription Drug Pricing Reduction Act of 2019; issues related to Medicare Advantage; issues related to Price Transparency; issues related to H.R. 3, the Elijah E. Cummings Lower Cost Act of 2019.
Monitored issues related to surprise medical bills including H.R 3502, H.R. 861, H.R. 3630, H.R 2328; issues related to S.1895 the Lower Health Care Costs Act of 2019 and issues related to transparency. Issues related to P.L. 116-123, the Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020; P.L. 116-127, Families First Coronavirus Response Act. P.L. 116-136., Coronavirus Aid, Response, and Economic Security Act (CARES Act).
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN TRUCKING ASSOCIATIONS via THE NICKLES GROUP, LLC
2020 · first_quarter · Q1
Issues related to hair testing.
Filing targets: Executive Office of the President (EOP)
ACCENTURE FEDERAL SERVICES LLC via THE NICKLES GROUP, LLC
2020 · first_quarter · Q1
Monitored issues related to the Affordable Care Act and the federal exchange; issues related to HRSA.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE
BLUEBIRD BIO via THE NICKLES GROUP, LLC
2020 · first_quarter · Q1
Issues related to drug pricing including S. 2543 Prescription Drug pricing Act and issues related to value based payment over time; H.R. 5882 the GENE Therapy Payment Act; H.R. 3 Elijah E. Cummings lower drug costs act; issues related to Medicaid Best Price and AMP reporting. Issues related to H.R. 3935, the Protecting Patients Transportation to Care Act.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SEND RELIEF, INC. via THE NICKLES GROUP, LLC
2020 · first_quarter · Q1
Issues related to disaster relief and Covid-19.
Filing targets: Executive Office of the President (EOP), Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE
JOHNSON & JOHNSON SERVICES, INC. via THE NICKLES GROUP, LLC
2020 · first_quarter · Q1
Issues related to drug pricing and transparency; issues related to S. 1895, Lower Health Care Costs Act of 2019; S. 340, CREATES Act of 2019; issues related to the regulation of cosmetics; monitored issues related to P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act); issues related to maternal mortality.
Issues related to biosimilars; S. 2543, Prescription Drug Pricing Reduction Act of 2019, issues related to ASP reporting; H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act.
H.R. 1158, the Consolidated Appropriations Act of 2020 and H.R. 1865, Further Consolidated Appropriations Act, 2020.
AMERICAN SOCIETY OF ANESTHESIOLOGISTS via THE NICKLES GROUP, LLC
2020 · first_quarter · Q1
Issues pertaining to administration of anesthesia services for veterans.
Issues related to drug shortages; issues related to scope of practice; S. 1895, Lower Health Care Costs Act of 2019; H.R. 861, End Surprise Billing Act of 2019; H.R. 3630, No Surprises Act; H.R. 3502, Protecting People from Surprise Medical Bills Act. P.L. 116-136., Coronavirus Aid, Response, and Economic Security Act (CARES Act).
Issues related to rural anesthesiology; monitored issues related to Medicare for All; issues related to scope of practice.
AMERICAN TRUCKING ASSOCIATIONS via THE NICKLES GROUP, LLC
2020 · first_quarter · RR
Issues related to controlled substances.
Issues related to controlled substances.
GILEAD SCIENCES, INC. via THE NICKLES GROUP, LLC
2019 · fourth_quarter · Q4
Issues related to the reimbursement of CAR-T therapy; monitored issues related to S. 2543, Prescription Drug Pricing Reduction Act of 2019 and H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
CSL BEHRING LLC via THE NICKLES GROUP, LLC
2019 · fourth_quarter · Q4
Monitored issues related to prescription drug pricing. H.R. 2296, the METRIC Act. Monitored S. 1895, Lower Health Care Costs Act of 2019, as it relates to pricing transparency and drug pricing. H.R. 2113, Prescription Drug STAR Act.
H.R. 1158, the Consolidated Appropriations Act of 2020; H.R. 1865, Further Consolidated Appropriations Act, 2020, as it relates to the self-administered drug list.
Issues related to home infusion and DME self-administered therapies. Issues regarding coverage reimbursement of biologics and plasma therapies. Issues pertaining to drugs listed on the Self-Administered Drug list. H.R. 2296, the METRIC Act. Monitored issues related to H.R. 2905, Medicare IVIG Access Enhancement Act. H.R. 2113, Prescription Drug STAR Act. Monitored S. 2543, Prescription Drug Pricing Reduction Act of 2019. H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act.
CLEVELAND CLINIC FOUNDATION via THE NICKLES GROUP, LLC
2019 · fourth_quarter · Q4
Issues regarding proposals to reduce health care costs; monitored issues related to drug pricing and drug shortages. Issues related to H.R. 1309, Workplace Violence Prevention for Health Care and Social Service Workers Act. Monitored issues related to price transparency. Monitored issues related to H.R. 3630, No Surprises Act, H.R. 2328, Reauthorizing and Extending Americas Community Health Act and S. 1895, Lower Health Care Costs Act of 2019, as it relates to surprise billing. Monitored S. 1399, Title VIII Nursing Workforce Reauthorization Act of 2019.
Monitored issues related to prescription drug pricing. Issues related to CAR T-cell therapy reimbursement. Issues regarding telehealth. Issues regarding PPS exempt hospitals. Issues regarding price transparency.
METROPOLITAN LIFE INSURANCE COMPANY via THE NICKLES GROUP, LLC
2019 · fourth_quarter · Q4
Issues related to the implementation of The Tax Cut and Jobs Act, in particular the taxation of insurance and the taxation of foreign earnings of U.S. multinational corporations. S. 972, the Retirement Enhancement and Savings Act of 2019 and H.R. 1994, the SECURE Act, as they relate to employer pensions plans. Issues related to the Health Insurance Tax.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
S. 2543, Prescription Drug Pricing Reduction Act of 2019, issues related to ASP reporting; issues related to Medicare coverage of vaccines.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of the Vice President of the United States, SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)
S 3404, VALID Act and regulation of pharmcogenomic tests.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE, White House Office
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Monitored issues related to non profit status. H.R. 3300, Economic Mobility Act of 2019 and H.R. 1865, Further Consolidated Appropriations Act, 2020, as they relate to transportation of fringe benefits.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE